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Abstract

ACU TE GABA-A RECEPTOR MOD U LATION BY DIAZEPAM FOLLOWING
TRAUMATIC BRAIN INJ U RY IN THE RAT: AN IMMUNOHISTOCHEMICAL
STUDY
Cynthia 1. Gibson, Bachelor of Science
A thesis submitted in partial fulfillment of the requirements for the degree of Master of
Science at Virginia Commonwealth University .
Virginia Commonwealth University, 2000
Major Director: Robert J. Hamm, Ph.D ., Department of Psychology

Traumatic brain injury ( TBI) disrupts ionic balance and produces acute
widespread depolarization. Restoration of ionic balance and neuronal function after TBI
may be achieved by increasing inhibitory neurotransmission (e.g., stimulating GABA-A
receptors) . This study used antibodies specific for P2/3 subunits to examine changes in
GABA-A receptors in the rat hippocampus 24 hours following moderate fluid percussion
TBI. The P2/3 antibody primarily stained dendritic processes. No injury related changes
were found in the CA 1 but extensive morphological dendritic alterations were found in
the CA3 region of the hippocampus. Analysis revealed decreased length of
immunoreactive processes in CA3 apical dendrites of injured animals . These changes
may represent a sublethal cytoskeletal response to excessive neuroexcitation .

XIV

Administration of diazepam 15 minutes prior to injury augmented IR P213 processes
compared to injured/vehicle and sham groups. This study illustrates that GABA-A
receptors are altered following TBI and these alterations may be attenuated by increasing
inhibitory neurotransmission .

Chapter I: Traumatic Brain Injury

Human Traumatic Brain Injury
Incidence
Traumatic brain injury (TBI) affects approximately two million people per year in
the United States, resulting in 500,000 hospitalizations ( Ommaya, Ommaya, Dannenburg,
& Salazar , 1996). The 10% overall mortality rate (Pope & Tarlov , 199 1) translates into

TBI as the third leading cause of death (Sleet, 1987) . This represents 2% of all deaths and
26 . 1% of all injury-related deaths . Overall estimates indicate that approximately 4% of
the population will suffer a TBI by the age of 19. TBI may affect children's intellectual
capabilities, with about 33% of children who remain unconscious greater than one week
having IQs less than 70 (Poper & Tarlov , 199 1) . Overall, 4% (75,OUO) of TBI patients
will be left with long-tenn neurological deficits (Cole & Edgerton , 1990).
Public concerns regarding the costs of TBI have become apparent in recent years .
In 1987, The US Department of Education, National Institute on Disability and
Rehabilitation Research funded the TBI Model Systems of Care, for the development of a
comprehensive model care system for TBI patients and their families. This ongoing
project is a longitudinal, multi-center study, continuously updated in a standardized
national database (Harrison-Felix, Newton, Hall, & Kreutzer, 1996) . In 1996, the
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Traumatic Brain Injury ( TBI) Act (Public Law 104- 166) was adopted by Congress in
order to expand studies and establish new TBI-oriented programs . By 1999, Health
Resources and Services Administration, Maternal and Child Health Bureau required
implementation of TBI State Demonstration grant programs for TBI patients and families
to improve health and community services in the areas of planning and implementation
grants to states ( Traumatic brain injury state demonstration grants, 1998 & 1999).
Children and the elderly are at high risk for TBI but the peak risk lies between 15
and 24 years . Males represent up to 70% of TBIs, and nonwhite, urban populations are at
the greatest risk (Pope & Tarlov, 199 1). Fatality rates are three times higher for males
than for females (Sosin, Sacks, & Smith, 1989) . Demographics indicate that the average
age for a TBI patient is 35. Patients less than 15 years tend to have the shortest hospital
stays, those 15-24 have the longest stays, and those over 45 have relatively long hospital
stays. More than 50% of TBI patients have a positive blood alcohol level (BAL) at
admission, with 39% greater than 0. 1 BAL . More than half of all TBls occur on weekends
between 8 p .m . and 4 a.m. (Harrison-Felix et ai., 1996).
In 1996, automobile crashes, the leading cause of TBI, accounted for 56% of all
cases, with falls representing 10% and violence/ intentional injuries also a major
contributor (30%) (Harrison-Felix et ai., 1996). Compared to falls, more severe injuries
are likely to be associated with auto crashes, resulting in higher incidence of concussion
and lower incidence of hematoma ( Kalsbeek, McLaurin, Harris, & Miller, 1980). Auto
crashes account for 57% of TBI-related mortality (Sosin, Sacks, & Smith 1989) and
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hospital stays twice as long as other causes ( Kalsbeek et al., 1980) . TBI due to motor
vehicle crashes is 39% higher for Caucasians than for African Americans (Sosin, Sacks,
& Smith 1989), is more likely to be associated with diffuse injuries (Pope & Tarlov,

1991), and accounts for approximately 49% of the total costs of TBI. This is likely due to
the more severe nature of the injuries ( Grabow, Offord, & Reider, 1984).
Epidemiology - Mild, Moderate and Severe Injury
Many discrepancies have been noted in the classification of injury severity. On
average, 60% of injuries are mild, 20% are moderate and 20% are severe (Frankowski,
1986) . The Glasgow Coma Scale ( GCS) is the most accepted rating scale for measuring
injury severity. Mild injury is generally classified as a GCS score of 13-15, moderate
injury is represented by a score of 9- 12 and severe injury receives a score of 3-8. These
are general categories and do not represent a strict definition. Various hospital emergency
rooms and research studies may define the cut-off points differently. Many other factors
are considered that may influence the severity judgement. Because so many variables are
involved, and the GCS score is subject to each doctor's interpretation, there is much
controversy in the literature regarding the reliability of the scale. The GCS score factors
include eye, verbal and motor reactions. Also taken into account are length of
unconsciousness, duration of amnesia or confusion, surgical requirements (such as
removing blood clots), secondary insults such as seizures or ischemia, skull fractures and
computerized tomography (CT) scan results (Colohan & Oyesiku, 1992) . Mild, moderate,
and severe injuries have varied pathologies and neuropsychological consequences .
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Mild TBI
Mild injuries generally do not include a period of unconsciousness, yet the
average cost of treatment is $44,0 14 ( Lehmkuhl, Hall, Mann, & Gordon, 1993).
Cognitive impairments following mild head injury have not received much attention
because the deficits may be subtle . Many patients complain of post-concussive symptoms
such

as dizziness, headache, nausea, and

confusion. Links between posttraumatic

headaches and cognitive deficits were examined in one retrospective study, designed to
evaluate symptoms such as concentration, memory and thinking deficits . In a sample of
patients with post traumatic headaches, 65% reported cognitive problems (62% of these
were confirmed by a doctor). The cognitive areas least affected by a mild injury included
overall intelligence, language, perceptual and motor functions. The most prevailing
cognitive deficits included problems with memory, attention, and information processing.
Attention (concentration) was the most affected, followed by memory. Information
processing problems typically diminished within three months of injury, whereas memory
problems were not always noticeable during the first three months following injury. Age
and gender did not seem to be significant factors in mild injury, although females tended
to have more symptoms . Most cognitive impairments diminished gradually over the
course of the first year post injury (Packard, Weaver, & Ham, 1993). Memory, attention
and information processing deficits were likely to have an impact on the patient's lifestyle
and job performance ability.
Moderate TBI
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Moderate TBI tends to result in an average of five days of unconsciousness, and a
mean treatment cost of $85,682 ( Lehmkuhl et aI., 1993). The outcome from moderate
TBI varies widely. GCS scores of nine or ten have a 7-9% mortality rate and a much
slower recovery compared to GCS scores of 1 1 or 12, which rarely result in death and are
often moved to the mild category within 24 hours. Failure to return to work is estimated
at 69%, a substantial increase over the estimated 34% for mild injuries ( Rimel, Giordani,
Barth, & Jane, 1982). Moderate injury often results in more impairment than mild injury
does, with 49% retaining a moderate disability, 10% a severe disability, and a 3%
mortality rate from injury related complications. This leaves only 38% who are classified
as 'good recovery . ' Memory problems, which effect 90% of moderate injury patients, are
the primary reason for unemployment. Predominating impairments tend to be in areas
related to higher-level cognitive skills such as problem-solving, attention, visual reaction
times, and memory for auditory and visual tasks . Overall intelligence does not seem to be
greatly affected. The location and size of brain lesion resulting from the injury are related
to the type and severity of the impairments (Colohan & Oyesiku, 1992) .
Severe TBI
Severe TBI is represented by 12-34 days of unconsciousness, with an average cost
between $ 1 1 1,000 and $ 154,000 ( Lehmkuhl et aI., 1993). Severe head injury is more
complicated and life-threatening than dther mild or moderate injury. In one study of
severely injured patients, 68% died during their hospital stay, 13.3% died shortly after
discharge, and 6 . 1% remained in a vegetative state six months later . Only 12.5% were
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classified as functional survivors. Older patients ( 100% of those over 50) were the most
likely to die . Functional recovery was only seen in patients less than 30 years of age . Low
GCS scores and abnormal pupil responses were strong indicators of mortality (Quigley et
ai., 1997).
Functional survivors of severe head injury are likely to face a lifetime of
neuropsychological and physical disabilities . Only 3% return to comparable employment
levels (Wehman et ai., 1993) . Several pilot programs are in place across the country to
provide supported employment to victims of severe brain injury. One such study,
conducted in Richmond, VA, accepted 1 15 clients who had suffered a severe injury ( GCS
score less than eight for more than six hours), resulting in severe impairments. Clients
were placed in payed, real-work positions and all vocational intervention, job training and
behavioral modification were provided at the job site. Most of the clients had deficits of
attention, motor speed, verbal learning, verbal memory and .visual memory. Average
scores on the Wide Range Achievement Test-Revised showed deficiencies in arithmetic,
spelling and problem solving (scores less than the 20th percentile). After five years of this
program, 70% had been placed in competitive employment for an average of 45 weeks .
The mean annual income of these 80 clients was $7079 per year (Wehman et ai ., 1993).
The Costs of TBI
The monetary costs of TBI are staggering. In 1985, direct costs from mortality and
morbidity totaled $37.8 billion ( Ommaya et ai ., 1996) . According to a 1985 report to
Congress on the incidence of injuries in the U.S., although only 13% of injuries are due
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to TBI, they account for 25% of injury-related mortality and 29% of the total injury costs
( Rice, Mackenzie, & Associates, 1989) . Fatal cases (6.3%) account for 84% of the total,
including funeral costs and loss of revenue ( Grabow, Offord, & Reider, 1984). Gunshots
( $ 164,250) and motorcycles ( $ 165,294) account for the highest mean charges, while
assaults ( $89,940) account for the lowest charges ( Lehmkuhl et ai., 1993).
In 1995, the average acute care cost was approximately $ 105,800 and the average
rehabilitative care was $58,400 (Harrison-Felix et ai., 1998). A large portion of these
costs are paid for by public funds. In 1992, military hospitals paid almost 42 million
dollars for TBI-related injuries, the median cost per patient being $35,400 ( Ommaya et
ai ., 1996). Estimates indicate that 29-3 1% of acute care and 3 1-39% of rehabilitative care
are paid for by Medicare or Medicaid (Harrison-Felix et ai, 1996; Lehmkuhl et ai., 1993).
In one year in the US, more than 40,000 patients are estimated to have spent three weeks
or more in the hospital due to TBI. Further costs to the public include loss of
employment . Approximately 39% of those employed at the time of injury are unable to
return to work one year later (Harrison-Felix et ai., 1996) . The indirect costs of TBI
include short term intellectual, motor, and learning impairments and long term
rehabilitation, revenue loss, and intellectual limitations such as memory and
concentration deficits.
Injury Pathology
Types of Injuries
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The mechanism of injury detennines the type of injury and the resulting
pathology. There are two main types of brain injuries. First, injuries are classified as
either penetrating or non-penetrating. A penetrating injury, from a bullet or other object,
may cause brain lacerations and hemorrhage. Non-penetrating injuries usually result from
blunt impact of the brain with the inside of the skull. These closed head injuries are
known as acceleration-deceleration and may occur either linearly or rotationally within
the skull. The second major injury type refers to focal or diffuse injuries. A focal injury is
limited to a specific region of the brain, resulting in contusion, laceration, hemorrhage,
and/or infarction. Focal injuries may result from penetrating or non-penetrating blows to
the head. The frontal and temporal lobes are especially vulnerable to focal injuries.
Diffuse injury is most likely due to non-penetrating acceleration-deceleration or rotational
type injuries but may also include axonal injury and secondary loss due to hypoxia or
ischemia. Secondary insults often result from increased intracranial pressure (ICP) or
cardiovascular collapse following a closed head injury. Diffuse injuries typically lead to
specific patterns of necrosis in the cortex and infarctions of the hippocampus and basal
ganglia (Selzer, 1995) .
Primary and Secondary Injuries
Primary brain injury occurs due to the mechanical forces involved at the moment
of impact. Primary damage includes surface contusion and laceration, diffuse axonal
injury (DAI) and intracranial hemorrhage . Primary (mechanical) damage affects blood
vessels, axons, neurons and glia and may represent a focal, multi-focal or diffuse pattern
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of injury. DAI, focal contusions and intracranial hematomas due to hemorrhage provide
the potential for secondary damage such as ischemia, hypoxia, cerebral swelling/edema,
increased ICP, hypotension, and seizures (Alessandri & Bullock, 1998).
Primary methods of injury include contact of the skull with a foreign object or
unrestricted head movement due to acceleration-deceleration forces of the brain within
the skull. Contact injuries primarily result from falls and result in focal damage such as
local or regional lesions, skull fracture (with or without extradural hematoma), surface
contusions and intracranial hemorrhage. Acceleration-deceleration injuries primarily
result from motor vehicle crashes and produce diffuse types of injuries. Shear, tensile and
compressive strains often occur following diffuse injuries and may result in subdural
hematomas (SOH) and widespread axonal damage (McIntosh et ai., 1996).
Secondary damage involves changes that are initialized at the time of impact. The
biochemical cascade of events that follows involves changes .leading to neuronal damage.
Please see Table 1 for a summary of primary and secondary consequences of TBI.
Neuronal cell body injury in the gray matter occurs in stages. Neurons in direct
contact with an object or the skull die immediately and form a core of primary damage.
Damaged neurons release excessive excitatory amino acids (EAA), resulting in further
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Table l. Common types of primary and secondary damage following TBI.
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Common Forms 0.( Primary and Secondary Damage
Type of Injury

Type of Damage

Laceration (cuts)

Primary

Contusion (bruising)

Primary

Disturbed ion gradients

Primary

Edema (swelling)

Primary I Secondary

Hematoma (due to hemorrhage)

Secondary

Ischemia (decreased blood flow)

Secondary

Hypoxia (decreased oxygen)

Secondary

Diffuse Axonal Injury (DAI)

Secondary
(Prim<llYat membrane)
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depolarization and calcium entry into nearby neurons . Secondary changes are more
complicated and prolonged.
Further complicating the injury potential, delayed secondary damage may be more
severe than the initial loss. Secondary damage may include ischemia, swelling (edema),
and alterations of normal neurochemical functions and mechanisms . Secondary damage
may not present clinically for hours or even days providing a potential window for
intervention. Recovery begins with neurons that may have been damaged but not killed .
The initial core of immediate damage, therefore, often spreads to a secondary "penumbra"
of neuronal damage and then to a potentially reversible "outer zone" of neuronal
dysfunction (Selzer, 1995) .
Excitotoxicity and Excitatory Amino Acids
Glutamate is the most widely distributed excitatory neurotransmitter in the brain.
High concentrations of glutamate are toxic . High levels (10 to 200 flM) are released into
the extra-cellular fluid (ECF) following injury (Alessandri & Bullock , 1998). The
excitotoxicity hypothesis, as it relates to TBI, postulates that activation of muscarinic
cholinergic and/or N-methyl-D-aspartate (NMDA) type glutamate receptors is probably
due to excessive neurotransmitter release following TBI-induced depolarization of
neurons. This over-excitation then contributes to resulting TBI pathophysiology (Hayes,
Jenkins, & Lyeth , 1992b) . GlutamatergiC receptor antagonists administered before injury
have been shown to reduce histological, functional and behavioral consequences in
animal models of TBI (Alessandri & Bullock, 1998). Neurochemical alterations
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following TBI are related to excitotoxic processes and abnormal agonist-receptor
interactions. Treatment potential lies in the possibility that neurochemical processes
which mediate brain pathophysiology associated with TBI may respond to
pharmacological therapies (Hayes, Jenkins, & Lyeth, 1992b).

Chapter II: Experimental Traumatic Brain Injury

Animal Models of TBI
Biomechanics of Experimental Injury
It is important that models of TBI mimic the mechanical forces, causes, and
consequences which occur in human patients . The mechanical loading forces include
impact forces and inertial (acceleration) forces . Brief (usually < 50 msec) mechanical
deformation results in brain injury. The type and extent of brain injury is dependent on
the location, magnitude and direction of the loading forces.
The most common mechanical causes of TBI are due to impact loading forces .
Impact loading refers to direct contact between the head and a solid object. These contact
effects result in local deformation of the skull, overall brain movement within the skull,
and potentially devastating tissue strain to the underlying neuronal tissue. Inertial loading
refers to indirect head movements resulting from an impact to other areas of the body.
Inertial acceleration effects produce an overall pressure distortion and neuronal tissue
strain which results in primary tissue damage (McIntosh et ai., 1996) .
Contact Effects and their resultinl;! Neuropathologic Sequella
Impact loading forces may result in skull fracture due to focally distributed forces.
Local skull depression produces distinctive stress zones caused by waves of distortion
14
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radiating from the point of impact. These waves disperse and meet at places within the
skull, causing additive pressure and potential skull fracture in areas other than the impact
site. Local skull distortion may also occur without overt fracture . The amount of local
skull displacement is an indication of the pressure and distortion experienced by
underlying tissue and the tissue affected by stress waves radiating from the point of
contact.
Impact forces produce contact effects such as skull bending, intracranial pressure
(ICP), and focal lesions due to contusions, laceration and hematomas. An intracranial
hematoma is often considered a more extensive form of contusion and a subdural
hematoma is due to vascular damage underlying the impact site. Epidural hematoma is
more likely caused by tom vessels due to fracture (85%) than to ICP ( 15%) (McIntosh et
ai., 1996).
Inertial Cacceleration)Eeffects and their resulting Neuropathological Sequella
Acceleration due to impact or impulsive loading produces a different type of
injury with different mechanical effects . There are two primary types of inertial effects:
translational acceleration (acceleration-deceleration movement along a straight path) and
rotational acceleration (brain rotation within the skull) . Translational acceleration
produces movement of the brain within the skull and increased ICP . The magnitude of
peak ICP is directly due to the level of tninslational acceleration. Rotational acceleration
produces widespread tissue strain within the brain and the shear strain is directly related
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to the level of rotational acceleration, direction of motion , and potential intracranial
impact with dural compartments such as the tentorium cerebri (McIntosh et aI., 1996).
Assumptions and Hypotheses in Animal Modeling
Animal models rely on the hypothesis that human injury can be duplicated in
nonhumans. Some assumptions must be made in order to allow generalization from a
model to human conditions. Species differences are assumed to be of minimal
consequence, and the injury production mechanism is not considered as important as the
resulting sequella. Knowing the injury mechanism in humans is, however , important for
safety measure development and prevention.
There are several important aspects of injury that should be represented in a good
animal model. These include: the mechanism of injury, the location of brain damage, the
type of damage produced, the severity and time course of injury, and long term and short
term changes. The model should also be able to effectively assess morphological changes,
cerebrovascular changes, metabolic receptor changes, and behavioral changes
( Gennarelli, 1994).
Overview of the models by Injury Classification
Acceleration Concussion and Percussion Concussion
Denny-Brown and Russell ( 1941) distinguished two categories of injury: (a)
acceleration concussion and (b) percussion concussion. Acceleration concussion is
modeled by inertial injury models. These models produce acceleration without impact or
with diffuse loading and have been used in primates , cats, and swine. Another
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acceleration concussion model is impact acceleration, which is also referred to as the
weight drop model . Impact acceleration involves an impactor such as a piston or weight,
which is dropped directly on the skull or onto a steel plate covering the skull. The latter
minimizes localized skull loading and fracture. This model has been demonstrated
effectively in primates, cats, and rats ( Gennarelli, 1994).
Fluid percussion (FP) injury is a widely used model of percussion concussion .
This model was used in cats until 1987, when it was modified for use in rats due to their
compatibility with behavioral tasks. The central, lateral, or lateral with contralateral dura
opening variations of the model have also been used in dog, rabbit, and swine . In this
model, a small fluid volume is injected into subdural or supradural space . Impact is
provided via a fluid column or rapid pump infusion .
Another model of percussion concussion is rigid indentation , also known

as

controlled cortical impact (CCI). In this model, a piston strikes the brain directly through
a large craniotomy hole. Impact is controlled at about 2 to 3 mlsec and penetrates 2 to 3
mm deep. Variations of this model include central, lateral , or lateral with contralateral
open dura injuries.
Other models of injury that have very specific usefulness include injection
models, where a small amount of fluid or blood is injected into epidural, subdural, or
intracerebral brain locations. Local tensile models produce injury under pressure or
suction of the open dura ( Gennarelli, 1994).
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The most frequently used animal models ofTBI include central or lateral FP,
central or lateral CCI, weight drop, and injection models (for subdural hematoma
injuries). Areas of particular interest to the excitotoxicity hypothesis of injury include:
DAI, contusion, fracture, acute subdural , epidural, or intracerebral hematoma, and brain
swelling (Alessandri & Bullock, 1998) . Animal models have done well in their attempts
to model morphological changes following TBI but areas that are less well characterized
include neurological changes such as cognition, memory and long-term outcome;
physiology as in cerebral metabolism; and biochemistry, such as gene expression and
ionic changes ( Gennarelli, 1994).
Excitotoxicity
Models that involve glutamate infusion have been shown to activate all glutamate
receptor subtypes. Glutamate is then removed from the synapse by astrocytes. Other
excitotoxic infusions such as kainic acid, N-methyl-D-aspartate (NMDA), or a-amin-3hydroxy-5 methyl-4 isoxazale proponic acid (AMPA) do not have this property
(Alessandri & Bullock, 1998). Excitotoxicity of glutamate has been demonstrated to
produce hypermetabolism , which is neuro-protected with NMDA and AMPAlKainate
(AMPNKA) receptor antagonists such as D-CPPene, M K-80 1 , and NBQX , as well as
with the free radical and lipid peroxidase inhibitor 174006F and D-amphetamine
(Fujisawa, Landolt, & Bullock, 1996; Hovda et aI., 1995; Sutton , Hovda, Chen , &
Feeney, 2000) . These in-vivo models of excitotoxicity provide support for the potential
damage of excessive glutamatergic activity. Glutamate infusion damages cortical tissue
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synergistically following FP injury, likely due to the increased vulnerability of neurons to
glutamate following injury (Bullock & Di, 1997). Although glutamate is the best
characterized excitotoxin, ACh and kainic acid also have excitotoxic properties that have
been demonstrated both in vitro and in vivo ( Regan & Choi, 199 1). The concentrations
needed to kill cortical neurons are lowest for NMDA, then AMPA , and kainic acid,
respectively. The strongest excitotoxic effects are produced by glutamate which binds to
the NMDA receptor subtype ( Regan, 1996).
Experimental Models of Focal and Diffuse Brain Injury
Physical, computer and cell culture models have all contributed to the
understanding of specific aspects of head injury . However, animate models are the only
true representations of the complex changes that occur within a living organism in
response to brain trauma . Two distinctions have been made in model type: focal and
diffuse (McIntosh et aI ., 1996). Each of these types of injuries. have their own sequence of
changes and cascades of events, some of which are similar and some of which are
distinctively different.
Focal injury models describe the pathology concerning contact effects from
impact forces . Cortical contusion is common to focal injuries and has been well
characterized in rats (Dixon et aI., 1987; Dixon, Glifton, Lighthall, Yaghamai, & Hayes,
199 1; Feeney, Boyeson, Linn, Murray, &'Dail, 198 1; McIntosh et aI., 1989; Nilsson,
Ponten, & Voight, 1977; Shapira et aI ., 1988; Toulmond , Duval, Serrano, Scatton, &
Benavides, 1993), mice, cats ferrets, pigs, and other primates ( Lighthall, 1988; Lindgren

20
& Rinder, 1965; Ornrnaya, Hirsch , & Fl amm , 1966; Smith et ai., 1995; Sullivan et ai .,
1976). Primary skull displacement lasting approximately 10-30 msec occurs due to
contact (focal) loading forces (McIntosh et ai., 1996) . TBI with contusion may be
analogous to ischemic focal forebrain infarction (Hayes, Jenkins & Lyeth , 1992b). TBI
models that produce cortical contusion may also cause damage to areas remote from the
injury site (McIntosh et ai ., 1996) .
Several models are available that can produce a focal injury (see Table 2) ,
including weight drop (Feeney et ai, 198 1; McIntosh et ai., 1989; Nilsson, Ponten, &
Voight, 1977), fluid percussion (Dixon et ai ., 1987; Lindgren & Rinder , 1965; McIntosh
et ai ., 1989; Toulmond et ai., 1993), and rigid indentation (Dixon et ai., 199 1; Soares,
Thomas, Cloherty, & McIntosh, 1992; Smith et ai ., 1995) . A common feature of each of
these models is that the head is held steady in one position as the injury occurs (McIntosh
et ai., 1996) . The weight drop model often produces contusion at the injury site, neuronal
loss of the hippocampi, thalamus and brain stem nuclei, and may produce skull fracture,
prolonged coma, DAI and seizures (Beaumont et ai ., 1999; Foda & Marmarou, 1994;
Gennarelli, 1994; Marmarou et ai., 1994; Povlishock, Hayes, Michel & McIntosh , 1994).
The rigid indentation model (CCI) normally produces a focal contusion at the injury site,
axonal damage, and lower mortality due to less brain stem damage , compared to the
cortical weight drop model (Povlishock et ai., 1994). Central rigid percussion produces
coma , contusion to the parasagital cortex under the impact site and non-diffuse axonal
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Table 2. The injury characteristics of animal models of TBI.
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Current Uses of Animal Models
Animal Model

Cortical weight drop/

Focal/ Diffuse Injury

Focal

Uses- Injury Type

contusion

Species Studied

rat

neuronal loss

Impact Acceleration

potential seizures
impaired motor ability
Cortical impact (CCI)

Focal

contusion

rat, ferret

axonal damage
Fluid Percussion (FP)

Both Lateral and

behavioral dysfunction

rat, cat, micropig, non-

Central effects:

brief coma

human primates

impaired motor ability
axonal injury
vascular abnormalities
neurochemical changes
possible contusion'
Focal ( Lateral)

neuronal cell loss

Diffuse (Central)

brain stem involvement

unilateral damage
bilateral damage
Inertial injury

Diffuse

Full spectrum of human

micropigs and non-

head injury, morbidity,

human primates

and coma
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damage. Lateral CCI injuries produce a brief coma, a small amount of diffuse axonal
damage and contusion at impact site ( Gennarelli, 1994).
In the FP model, fluid is injected through a sealed cannula-type hub into the
closed cranium. This model has been well characterized. It has been associated with
behavioral detriments, transient coma, impaired motor function, and altered learning and
memory (Povlishock et ai., 1994). Structural abnormalities have been noted, including
subarachnoid hemorrhage and axonal injury. Cell loss in the cortices and hippocampi is
common in moderate severity injuries, with contusion likely at higher severities,
especially in lateral injuries ( Gennarelli, 1994). Cerebral vascular abnormalities in blood
flow and BBB permeability, neurochemical changes controlling ionic homeostasis, and
metabolic alterations have also been documented (Povlishock et ai., 1994) . For focal
injuries, the lateral FP model is preferable, with central FP model producing a more
diffuse type of injury Gennarelli, 1994; Povlishock et ai ., 1994) .
Lateral FP injuries (FPI) are more likely to result in focal contusion and cortical
changes are often unilateral to the side of injury, sparing the contralateral cortex and brain
stem. Ipsilateral changes in white matter axons and occasional deep tissue tears at gray
white matter junctions may occur. Unilateral hippocampal damage has been well
characterized ( Gennarelli, 1994) .
Central FP injuries are less likely to produce contusion and overt cell loss at the
impact site . Bilateral cortical responses and brain stem involvement (including axonal
injury) are common features of the central FP model ( Gennarelli, 1994; Mcintosh et ai.,
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1996, Povlishock et aI ., 1994) . FP injury, however, provides only limited biomechanical
control and does not represent the full human TBI spectrum of injury (e.g., prolonged
unconsciousness). Higher severity levels of injury are often complicated by brain stem
involvement and rats are more susceptible to the confound of pulmonary edema
(Povlishock et aI., 1994). Diffuse TBI-induced depolarization without contusion has
similar neuropathological consequences to diffuse forebrain ischemia, resulting in
selective neuronal deficits without overt cell loss (Hayes, Jenkins & Lyeth, 1992b) .
Species Studied
The choice of species in TBI modeling is important. There may be different
patterns and distribution of receptors between humans and various other species . This
must be weighed against the societal and financial expenses involved in using
phylogenetically closer species. Rodent animal models, particularly rats, have been well
characterized and have the benefit of providing extensive normative data . Their small size
and availability permits exhaustive structural and functional studies to be performed
(Povlishock et aI., 1994). Their age, genetic background, and environment can all be
controlled to reduce experimental variability, and their high infection resistence and
compatibility with neurochemical and neuropharmacological techniques have made them
a popular choice in animal models . Central fluid percussion injuries in rats have been
shown to be reliable at mild to moderate revels, without the complications of focal tissue
damage (Dixon et aI ., 1987) . Important similarities between humans and rodents include
impact depolarization and a high correlation between rodents' receptor pharmacology and
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neurochemical changes and humans ' TBI-induced behavioral deficits (Hayes, Jenkins &
Lyeth, 1992b). Rodents ' physiologic responses may differ from humans, however , and
they do not provide complete modeling of complex human changes due to their smaller
neocortex and their lack of complex gyri and sulci (Povlishock et aI., 1994) .
Links Between Fluid Percussion Injury and Human TBI
The pressure forces exerted on the brain during experimental FP injuries are
similar to those recorded from human cadaver skulls upon impact ( Lindgren & Rinder,
1966). Acute neurological symptoms and suppression of behavioral reflexes mimic
human unconsciousness/coma ( Teasdale, 1976) . Dixon et al . ( 1987) characterized the FP
model in rats, using neurological and histopathological endpoints following various injury
severity levels. Acute neurological evaluations indicated that mortality was positively
correlated with injury severity, with an average mortality for moderate injury around 3035%. A primary cause of mortality was pulmonary edema, which was not significantly
correlated with injury severity. Convulsions were only seen at higher injury levels (>2 . 1
A TM) and a positive correlation was found between injury magnitude and apneic
episodes (respiration cessa tion and resumption > I 0 sec) . Acute somatomotor responses
were developed to be similar to human reflexes on which GCS scores are based.
Somatomotor nonpostural responses correlated to injury magnitude included corneal and
pinna reflexes. Somatomotor postural responses, also correlated to injury magnitude,
included paw flexion , tail flexion, startle re fle x, and righting reflex. Sham animals were
normal within one minute of removal from the injury device . Systemic cardiovascular
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variables included: increased mean arterial blood pressure (MABP), which peaked within

10 sec and was not graded by inj ury severity level; brief bradycardia (5- 10 sec), with the
heart rates of all injury levels lowered to 50% of baseline, and decreases in pO] and pCO]
at high severity levels only. Plasma glucose increased at 5 min for all inj ury groups and
pulmonary edema ("pink fulminating exudate") increased carbon dioxide, lowered
oxygen and produced 100% mortality. Most of the measures documented in this study
(and others) show similarities to moderate human head injury, as measured by the GCS
(Dixon et aI., 1994).
The Hippocampus
Subsectors of the Hippocampus
The hippocampal formation is an elongated, C-shaped structure that wraps around
the diencephalon from the septal nuclei of the forebrain to the temporal lobe. The
hippocampal formation consists of four primary structures: the dentate gyrus (DG), the
entorhinal cortex (EC), the hippocampus proper, and the subicular complex. The
hippocampus proper is further divided into CA 1 , CA2 and CA3 regions. The structures of
the hippocampus have a distinctive laminar orientation. Although most of the
hippocampal connections are feed forward, GABAergic intemeurons also provide
feedback information to the original structure. The EC provides the major hippocampal
input via the perforant pathway, terminating primarily in the DG. The DG proj ects mossy
fibers to the CA3 fold of the hippocampus proper, which in tum projects to the CA 1
region. The subiculum receives the primary output from the hippocampus proper.
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Hippocampal structures communicate ipsilaterally via associational projections and by
commissural projections to the contralateral structures (Amaral & Witter, 1 995) (See
Figure 1 ).
Entorhinal Cortex
Information from cortical structures such as the perirhinal cortex, the tetrosplenial
cortex and the medial frontal cortex are relayed to the hippocampus via the EC. Feed
forward projections from the EC innervate the DG and the CA 1 and CA3 regions of the
hippocampus. The EC receives feedback information from the CA 1 and from the
subiculum. Projections from the EC to the hippocampal regions are collectively referred
to as the perforant pathway. The perforant pathway consists of projections from many EC
cell types, including stellate, pyramidal, GABAergic, and others (Amaral & Witter,
1 995).
The EC has two main subdivisions: the lateral entorhinal area (LEA) and the
medial entorhinal area (MEA) (Amaral & Witter, 1 995). The primary perforant pathway
projections are to the outer two-thirds of the molecular layer of the DG, where terminals
synapse on dendritic spines of granule cells. There are also some synapses on GABAergic
intemeurons. The LEA projects to the outer one-third of the molecular layer of the DG
and the MEA projects to the middle one-third of the DG (Hjorth-Simonsen, 1 972;
Nafstad, 1 967; Steward, 1 976; Witter, 1 993; Wyss, 1 98 1 ). The inner one-third of the DG
receives mossy cell projections from the polymorphic layer (Amaral & Witter, 1 995). The
perforant pathway also has some feed-forward projections to the CAl and
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Figure 1 . A diagram of a coronal section of the mid-dorsal hippocampal formation of the
rat. The primary connective pathways are shown: Schaffer collaterals (S), mossy fibers
(M), and the perforant pathway (P). The hippocampus proper is subdivided into CA 1 ,
CA2, and CA3 regions and the dentate gyrus (DG) is also shown.
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CA3 regions of the hippocampus proper, although only the CA 1 reciprocates these
projections (Amaral & Witter, 1 995; Nafstad, 1 967; Steward & Scoville, 1 976).
Dentate Gyrus
The laminar structure of the DG consists of the molecular layer, the granule cell
layer, and the polymorphic layer. The molecular layer primarily contains apical dendrites
of granule cells as well as some smaller stellate cell bodies. The granule cell layer,
consists primarily of granule cell bodies, although GABAergic basket cells are found
nestled between the granule and polymorphic layers (Amaral & Witter, 1 995). There is
approximately one basket cell to every 1 80 granule cells (Amaral, Ishizuka, & Claiborne,
1 990). The polymorphic layer, commonly referred to as the hilus, contains mossy cells as
well as basal dendrites and axonal projections of the granule cells.
Although relatively cell-free, the molecular layer does contain some basket cells
and axo-axonic interneurons known as chandelier cells (Amaral & Witter, 1 995). These
interneurons are primarily GABAergic, providing pre-synaptic input to the perforant
pathway and synaptic input to dendrites of the granule cells in the granule cell layer.
GABAergic chandelier cells may contribute to regulation of granule cell excitatory input
from the EC (Somogyi et aI., 1 985; Soriano & Fotscher, 1 989).
The granule cell layer consists primarily of granule cell somata which extend their
axons to the CA3 region. The stratum lucioum layer, found only in the CA3 region of the
hippocampus, consists of mossy fiber projections from the granule cells of the DG.
Mossy fibers bend temporally, forming an "end bulb," which demarcates the CA3 and
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CA2 regions of the hippocampus. Besides axo-axonic feedback from interneurons,
granule cells also receive synaptic input from basket cells, which are also primarily
GABAergic. Because of the wrapped orientation of the hippocampus, the molecular and
granule cell layer meet and form a ' V ' shape. The suprapyramidal blade refers to the
layered portion closest to the CA 1 and the infrapyramidal blade is furthest from the CA 1 .
Between the blades of this region, basal to the granule cell layer, is the polymorphic layer
(Amaral & Witter, 1 995).
Mossy cells are the most common cell type in the polymorphic cell layer. Mossy
cells have large triangular or multipolar shaped bodies with proximal dendrites covered in
spines or "thorny excrescences", which are termination sites of mossy fiber axons (Ribak,
Seress, & Amaral, 1 985; Frotscher, Seress, Schwerdtfeger, & Buhl, 1 99 1 ). These spines
are also seen in proximal dendrites of CA3 pyramidal cells. Primarily glutamatergic,
mossy cell projections may form as many as 37 synapses with.a single CA3 pyramidal
cell dendrite (Amaral & Witter, 1 995; Chicurel & Harris, 1 992).
Hippocampus Proper
The hippocampus proper consists of CA l , CA2, and CA3 regions. CA2 and CA3
areas contain primarily large pyramidal cells, whereas pyramidal cells of the CA l are
noticeably smaller. The narrow CA2 differs in poorly characterized connectional and
functional ways from CA 1 and CA3 regions. The border of CA2 and CA3 is marked by
the termination of the stratum lucidum, which is found only in the CA3 and consists of
mossy fiber projections from the DG.
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Hippocampal laminar organization is similar in all areas of the hippocampus
proper. The pyramidal cell layer is the main cellular layer. Basal dendrites extend into the
stratum oriens (SO) layer. Apical dendritic trees extend through the stratum radiatum
(SR) and stratum lacunosum-moleculare (SLM) layers. The SR layer receives input from
CA3 to CA l Schaffer collaterals. CA3 to CA3 associational (ipsilateral) and commissural
(contralateral) terminals are also located in the SR layer. Some EC perforant pathway
fibers travel and terminate in the SLM layer of the CA 1 , although the majority of
perforant pathway input is to the DG (Amaral & Witter, 1 995).
Although not well characterized, there is a variety of primarily GABAergic local
interneurons located throughout the layers of the hippocampus proper. The pyramidal cell
layer consists primarily of pyramidal cells but GABAergic basket cells are also present,
located along the SPI SO border (Seress & Ribak, 1 984). These basket cells are the most
common type of interneuron in the CA 1 . Basket cells of the SPI SO border directly
inhibit pyramidal cells in this region (Thompson, 1 994). The dendrites of the basket cells
appear beaded and have few dendritic spines. In contrast to the basket cells at the SPI SO
border, the interneurons at the SRI SLM border do not receive CA 1 input. These
interneurons terminate on the distal dendrites of the SO layer in the CAl (Amaral &
Witter, 1 995). Interneurons of the DG and CA3 receive direct cortical input from septal
projections (Amaral & Witter, 1 995; Freund & Antal, 1 988). CA3 interconnections to
both CA3 and CAl are divergent and extensive. As many as 6000 CA3 neurons ( 1 .9% of
the CA3 cell population) may innervate a single CA3 neuron. Also, a single CA 1 neuron
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may b e innervated b y a s many as 5 500 CA3 neurons ( 1 .8% o f the CA3 cell population).
CA3 projections may, therefore, play important roles in hippocampal inter
communication (Amaral, Ishizuka, & Claiborne, 1 990) ..
Subiculum
The primary output from the hippocampus proper originates in the CA 1 and is
relayed to the subiculum. The subiculum projects to the EC and also has minor
projections to other cortical areas, including the limbic cortex, the nucleus accumbens and
the lateral septal region. The aforementioned cortical connections to the subiculum in tum
project to the hypothalamus and the amygdala. The SR layer is not as prominent in the
subiculum and the SO and molecular layers widen to accommodate the enlarged
pyramidal cells (Amaral & Witter, 1 995).
Histopathology of TBI
The hippocampus is known to be vulnerable to ischemia, seizures and brain
trauma. Cognitive deficits are the most common long-term consequence of TBI in human
patients (McIntosh et aI., 1 996). Unlike ischemia, which produces damage in the CA 1
region, lateral TBI results in damage primarily in the CA3 and the hilus of the DG. Focal
models often result in cell loss in these areas (Cortez, McIntosh, & Noble, 1 989; Hicks,
Smith, Lowenstein, SaintMarie, & McIntosh, 1 993; Soares, Hicks, Smith, & McIntosh,
1 995; Smith, Okiyama, Thomas, Claussen; & McIntosh, 1 99 1 ). Loss of CA3 dendritic
processes is common in focal models of TBI (Hicks, Smith, & McIntosh, 1 995; Taft,

Yank, Dixon, & Hayes, 1 992). Axonal damage throughout the hippocampus and thalamus
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is often found, even in the absence of DAI (McIntosh et ai., 1996). Also, receptor binding
properties are disrupted and the seizure threshold within the hippocampus is lowered
(Dixon et ai., 1 99 1 ; Feeney et ai., 1 98 1).
Focal models of TBI have distinctive patterns of histopathological changes,
including: focal contusion, hemorrhagic contusions, necrosis, cavitation at injury site,
short unconsciousness, BBB disruption (primarily in the contused region), cerebral
edema, decreased CBF, and increased metabolism, mircoglial and macrophage
proliferation and recruitment, and the potential for delayed secondary insults (McIntosh et
ai., 1 996). Histopathological studies have shown that the presence of subarachnoid blood
may be the only observable pathology at low injury levels. Moderate and severe injuries
are likely to produce acute and chronic changes such as bilateral intraparenchymal
hemorrhage in the hippocampi. At post-acute survival times (PID 4-7), necrosis and
cavitation become evident at the site of inj ury (Dixon et ai., 1 987). Lateral injuries
produce radial contusion, structural damage, and cortical and hippocampal cell loss which
correlate with specific behavioral deficits (Delahunty, Jiang, Gong, Black, & Lyeth,
1 995).
Diffuse models of TBI are less likely to result in overt cell loss. Using the FP
model of inj ury, Delahunty et ai . ( 1 995) showed that central inj uries produced muscarinic
and metabotropic dysfunction without any overt cell loss. Small or no contusions were
observed.
TBI and Ischemia: Similarities and Differences
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Models ofTBI and cerebral ischemia both produce injuries that involve
neurotransmitters (NTs). The same excitotoxic hypothesis is applied to both types of
injury. Ischemia, unlike TBI, however, is associated with ATP energy stores depletion, as
well

as

changes in brain temperature and pH (Hayes, Jenkins, & Lyeth, 1 992).
TBI models with focal contusions are analogous to ischemia models with focal

cerebral infarction, both producing overt structural damage. Diffuse models ofTBI
without contusion produce injuries similar to diffuse forebrain ischemia models. Some
differences in histopathology exist between the two types of eNS injuries, and TBI does
not produce the brain temperature reductions that are associated with ischemia. Although
ischemia may be present in many severely injured TBI patients, TBI models must
distinguish between damage caused by TBI and damage caused by ischemia (Hayes,
Jenkins, & Lyeth, 1 992).
Experimental TBI : Time points and the Biphasic Model
Experimental TBI initiates a cascade of events that alters normal cell signaling
and neuronal over-excitation (Hayes, Jenkins, & Lyeth, 1 992). Excessive neuronal
excitation produces large measurable increases in extracellular potassium, which result in
further neurotransmitter (NT) release, leading to further depolarization (Faden,
Demediuk, Panter, & Vink 1 989; Gorman, O' Beirne, Regan, & Williams 1 989;
Katayama, Becker, Tamura, & Hovda, 1 990). Excessive depolarization and NT release
may produce changes to the intracellular signaling mechanisms, resulting in irreversible
or long-lasting alterations in cell functioning (Hamm, Temple, Buck, Floyd, & DeFord,
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1 999). Following the acute excessive excitation of neurons, a chronic phase of functional
neuronal depression begins (Hubschmann, 1985).
The biphasic hypothesis (see Figure 2) posits that there is an acute phase « 24h in
rats) of excessive neuronal depolarization. Increased levels of excitatory NTs and cerebral
metabolism have been demonstrated. During the acute phase, methods of intervention
that may be useful include excitatory NT antagonists, reductions in glutamate and ACh
levels, and decreased elevations in metabolism during the first six hours following inj ury.
Inhibitory agonists may also help reduce neuronal excitation (Hamm et aI., 1 999).
Massive ionic fluxes and EAA release following TBI require high metabolic energy,
measurable by increased glucose utilization (Alessandri & Bullock, 1 998). This
hypennetabolism may last for minutes or hours in rat animal models and is fol lowed by a
hypometabolism lasting days or weeks (Yoshino, Hovda, Kawamata, Katayama, &
Becker, 1 99 1 ).
The chronic phase ( > 24h in rats) of depressed neuronal activity has a duration
that is dependent on the severity level of injury. Decreases have been demonstrated in
cerebral metabolism, choline uptake, scopolamine-evoked release, and choline
acetyltransferase (ChAT) and acetylcholinesterase (AChE) immunoreactivity (lR).
Excitatory NT antagonists have been shown to be detrimental during the chronic phase,
although drugs that attenuate the depressed activation of the cholinergic and metabolic
systems may be of some usefulness (Hamm et aI., 1 999).
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Figure 2. Acute and chronic neuronal activity according to the Biphasic Hypothesis.
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Impact depolarization and BBB alterations
Ionic Flux
As demonstrated in Figure 3, impact is followed by injury-induced ionic flux
across the cellular membrane, leading to widespread neuronal depolarization and
indiscriminate NT release (Selzer, 1 995). Ionic homeostasis changes fol lowing TBI are
related to delayed neuronal death and degeneration. Calcium levels increase after injury,
especially in damaged regions, and may persist for 48 hours fol lowing FP TBI in rats.
Increased calcium activates proteases such as calpain, which may ultimately lead to
cytoskeletal degradation and neuronal death.
Excitotoxicity: Lethal and Sublethal Cellular Changes
Indiscriminate NT release includes the inhibitory opioids and GABA, which may
help to modulate the excitotoxicity induced by release of excitatory neurotransmitters and
amino acids. Pathologically high levels of excitatory neurotransmitters (ACh) and
excitatory amino acids (EAA) (glutamate and aspartate) are released, leading to
excitotoxicity within the cells (McIntosh et aI., 1 996).
Glutamate can produce powerful neurotoxic effects following CNS injuries such
as ischemia, hypoxia, and trauma (Regan & Choi, 1 994). Direct exposure can kill neurons
(Rothman, 1 985) and intermittent excessive exposure can produce delayed cell death
(Choi, 1 985; Choi, Maulucci-Gedde, & Kriegstein, 1 987). Excitotoxicity has been
documented acutely for many different types of brain injury. The resulting cascade may
produce deficits due to either sublethal cell signaling disruptions or overt cell death.
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Figure 3. A flow-chart of the neuronal cascade of events following TBI.
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Sublethal excitotoxic injury has been documented in mild to moderate TBI, due
partly to processes which depend on muscarinic and NMDA receptors. Dysfunctional cell
changes due to excitotoxicity, neurological deficits, hippocampal disturbances in
cholinergic circuits (which mediate spatial memory) and increased vulnerability to
secondary insults may occur in the absence of overt cellular death or axonal injury
(Hayes, Jenkins, & Lyeth, 1 992b). Areas of selective vulnerability to CNS insult have
been demonstrated in ischemia, hypoxia, hypoglycemia, epilepsy, and TBI (Brierly,
1 976). Selective vulnerability to sublethal cellular injury following non-contusional TBI
include the CA 1 , CA3 and dentate gyrus areas of the hippocampus and specific layers of
the neocortex ( Hayes, Jenkins, & Lyeth, 1 992b).
Neurotransmitter Changes Following TBI
Indiscriminate EAA release (i.e., glutamate) activates NMDA and AMPNKA
type ionotropic receptors as well as metabotropic receptors. Receptor activation leads to
opening of ion channels and subsequent calcium and sodium influx. Additional calcium is
released from intracellular stores via second messenger pathways. Ultimately, the cascade
results in alterations in gene expression and increased energy demand from high-affinity
glutamate carriers in neurons and astrocytes (Alessandri & Bullock, 1 988).
Increases in glutamate following FPI in rats peak within minutes and may last up
to one hour (Faden et aI., 1 989). These increases may be 7-8 fold in the cortex and 3-4
fold in the hippocampus of humans following TBI (Bullock, Maxwell, Graham, Teasdale,

& Adams, 1 99 1 ). Experimental FPI in rats produces increases in glutamate in the
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extracellular space that exceed 1 00% of nonnal within the first few minutes following
injury. Katayama et al. ( 1 990) found a 90% increase in glutamate in the hippocampus
within two minutes following moderate FPI in rats. Glutamate levels in the
aforementioned study returned to baseline within four minutes. Once released,
extracellular glutamate binds to a ligand-gated receptor (i.e., NMDA or AMPAIKA) and
produces a large potassium influx (Kawamata et aI ., 1 992).
Blood Brain Barrier Alterations
Alterations in the BBB introduce exogenous sources of NTs to the brain (Hayes,
Jenkins, & Lyeth, 1 992a). Moderate TBI without contusion in the rat leads to BBB
opening in the cortex and hippocampus (Povlishock & Lyeth, 1 989; Jiang et aI ., 1 99 1 a).
Injury allows greater penneability to exogenous (blood-borne) NTs and neuromodulators
(Koide, Wieloch, & Siesjo, 1 986). Acute BBB penneability in the cortex and
hippocampus have been documented for moderate FP TBI in rats (Povlishock & Lyeth,
1 989; Jiang et aI., 1 992). BBB penneability may last up to 1 5 hours (Ellis, Chao, &
Heizer, 1 989). Blood plasma ACh levels are 7-fold greater than CSF ACh levels
(Robinson et aI., 1 990) and may contribute up to 39% of ACh levels found in the CSF
following TBI (Robinson et aI., 1 990). BBB changes allow blood plasma constituents
(e.g., ACh) to access and influence the brain after injury, exacerbating excitotoxic effects
and receptor dysfunction.
Receptor Changes
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Several receptor mechanisms exist which may mediate and propagate acute postinjury excitotoxicity. Muscarinic cholinergic and ionotropic NMDA glutamate receptors
show decreased binding following injury (Hayes, Jenkins, & Lyeth, 1 992b). Muscarinic
cholinergic binding decreases 30-40% in the C A l and DG of the hippocampus by 3 hours
post-injury (Oleniak et ai., 1 988). The NMDA glutamate receptor subtype has a voltage
dependent magnesium (Mg) blockade. The Mg blockade determines the extent of NMDA
receptor involvement in TBI pathology following injury and excessive glutamate release.
NMDA receptor binding has been shown to decrease 1 2- 1 5% within three hours in the
C A l of the hippocampus following moderate TBI in rats. Most changes in glutamatergic
binding affinity occur in the NMDA-type receptors (Hayes, Jenkins, & Lyeth, I 992b).
NMDA and nonNMDA (AMPNKA) receptors are directly correlated to selective
patterns of vulnerability and damage in specific brain areas following TBI. Acute
decreases in receptor binding for NMDA-type receptors in the inner and outer layers of
the neocortex and the CAl striatum radiatum and molecular layer of the DG in the
hippocampus three hours post-injury, are not seen in AMPNKA or quisqualate-type
glutamate receptors (McIntosh et ai., 1 996; Miller et ai., 1 990).
Muscarinic and NMDA receptor interactions (via G proteins and the IP3 pathway)
have been implicated in aberrant intracellular effector cascades following TBI (e.g.,
changes in intracellular effectors, coupling efficiency, and early effector genes). The
above interactions may play an important role in sublethal TBI pathology. Sublethal
injury has been associated with decreased CA I muscarinic and NMDA receptor binding,
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increased CA l sensitivity to forebrain ischemia (first 24 hours), EEG spike frequency
from the affected CA 1 region, spatial memory deficits in the intact hippocampus and
Schaeffer-collateral CA 1 LTP suppression (Hayes, Jenkins, & Lyeth, 1 992b).
Receptor antagonists have been shown to have some limited usefulness in
attenuating the detrimental effects of TBl pathophysiology. NMDA antagonists such as
MK-80 1 , phencyclidine (PCP) and dextrorphan have been shown to have some
effectiveness in rat TBl models. Another potentially beneficial treatment is the muscarinic
ACh receptor antagonist scopolomine. These drugs are unlikely to be highly effective in a
clinical setting, however, due to their potential toxicity and the very short therapeutic
window (maximum 1 5-30 minutes in rats) associated with attempts to reduce
excitotoxicity due to NT release (Hayes, Jenkins, & Lyeth, 1 992b; Mcintosh et aI., 1 996;
Faden et aI., 1 989).
Treatment of the inhibitory system has been studied using chronic endpoints,
although the effects are less well characterized than the excitatory NT and receptor
antagonists. Chronic injections of pentylenetetrazol (PTZ), a GABAaR antagonist,
following injury induced seizure activity, which enhanced inj ured and harmed sham
cognitive performance in the MWM (Hamm, Pike, Temple, O'Dell, & Lyeth, 1 995).
Treatment with MDL 26,4791 Suritozole, a GABA-A receptor inverse agonist, was found
to be effective on MWM improvement (O'Dell & Hamm, 1 995). A single acute injection
of Diazepam within 1 5 minutes of injury has also been shown to effectively improve
MWM performance (O' Dell, Gibson, Wilson, DeFord, & Harnm , 2000). Collectively,
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these findings would indicate that acute modulation of the GABAergic system has
beneficial effects on attenuating TBI-induced chronic cognitive deficits.

Chapter III: The GABA-A Receptor

The Balance Between Excitation and Inhibition
Understanding Inhibitory Neuroprotection
The overexcitation induced by TBI is also characteristic of other types of CNS
insults. Simply identifying excessive excitation is unlikely to present the entire cascade of
events that occurs following injury. It is more likely that the normal balance between
excitation and inhibition has been disrupted, resulting in neurotoxicity. Alternative to
decreasing excitation, balance may also be restored by increasing inhibition. Impaired
inhibition of neocortical pyramidal neurons is found following hypoxia combined with
lowered brain temperature (Fuj isaki, Wakatsuki, Kodoh, & Shibuki, 1 999).
Inhibitory agonists have been studied extensively in ischemia and are
neuroprotective when administered within the first four hours following injury (Cross,
Jones, Baldwin & Green, 1 99 1 ; Inglefield, Wilson & Schwartz-Bloom, 1 997; Li, Siegel,

& Schwartz, 1 993; Schwartz, Huff, Yu, Carter, & Bishop, 1 994; Schwartz et aI., 1 994;
Shauib & Kanthan, 1 997). Diazepam and other GABA-A receptor (GABAaR) agonists,
when administered before or shortly after ischemic injury, have been shown to be
.
protective against morphological cell damage (Nishikawa, Takahashi, & Ogawa, 1 994)
and CA l pyramidal cell loss (Cross et aI., 1 99 1 ; Fujisaki, Wakatsuki, Kudoh, & Shibuki,
47
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1 999; Inglefield, Wilson, & Schwartz-Bloom, 1 997; Johansen & Diemer, 1 99 1 ;
Schwartz-Bloom et aI., 1 998; Wahlgren, 1 997), as well as attenuating GABAaR binding
detriments (Arika, Kanai, Murakami, Kato, & Kogure, 1 993; Inglefield, Wilson, &
Schwartz-Bloom, 1 997) and injury-induced decreases in chloride ion (Cl-) channel
currents (Sigel, Baur, Trube, Mohler, & Malherbe, 1 990). Diazepam has also
demonstrated its effectiveness in cognitive protection in TBI (O'Dell et aI., 2000).
A maj ority of the research regarding GABAaR agonist-mediated neuroprotection
has been done in ischemia. TBI and ischemia share similar pathologies. Both injuries
culminate in excitotoxic consequences affecting selectively vulnerable brain regions.
Important differences exist between the two types of CNS injuries. Global ischemia
lowers MABP and brain temperature (Inglefield, Wilson, & Schwartz-Bloom, 1 997) but
moderate diffuse TBI does not significantly alter either of these measures (O'Dell et aI.,
2000). The most studied brain region in ischemia research is the hippocampus (Shauib &
Kanthan, 1 997), where an important morphological difference between injury types is
evident. The CAl region of the hippocampus shows delayed degeneration at three to four
days post-ischemia (Li, Siegel, & Schwartz, 1 993), whereas diffuse TBI does not tend to
exhibit overt cell loss and lateral TBI selectively destroys CA3 and hilar neurons (Hayes,
Jenkins, & Lyeth, 1 992).
The excitatory input in the hippocampus is balanced by inhibitory processes, often
on the same cell. Pyramidal neurons receive synaptic input from both glutamate and
GABA receptors (Li, Siegel, & Schwartz, 1 993). Glutamate is a precursor to GABA.
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GABA is fonned when glutamic acid decarboxylase (GAD), which is only found in
neurons, removes a carboxyl group from glutamate (see Figure 4) (Luddens, Korpi, &
Seeburg, 1 995). GABA is the most prevalent inhibitory neurotransmitter in the brain,
exerting its effects primarily through the GABAaR complex. The GABAaR acts to
increase membrane hyperpolarization via modulation of a Cl- channel. The GABA-B
receptor differs from the GABAaR in both mechanism of action and neuroprotective
potential. The GABA-B receptor acts primarily through a G-protein-coupled second
messenger system to reduce the presynaptic release of various neurotransmitters
(Karlsson & Olpe, 1 989).
The GABAaR is potentiated by ligands which bind to sites specific for
benzodiazepines (BZs), barbiturates, alcohol, steroids, zinc ions (Zn+), or various
anesthetics (Marrow, 1 995; Roberts, 1 974). As many as 20-50% of all synapses in the
CNS use GABA as a neurotransmitter (Bloom & Iversen, 1 97 1 ). Other estimates contend
that GABAaRs may be present on all neurons in the brain (Wahlgren, 1 997).
Specific areas of the hippocampus, such as the SO and SR layers of the
hippocampus proper, have been estimated to use GABA in 80-95% of the synapses.
Although the pyramidal cell layer represents a much lower percentage of GABA-positive
cells (5-8%), approximately 1 1 % of the general hippocampal neuronal population is
GABAergic (Woodson, Nitecka, & Ben-Ari, 1 989). The prominent expression of
GABAaRs in hippocampal intemeurons indicates that inhibition is an important
mechanism for maintaining the excitatory balance in neurons (Gao & Fritschy, 1 994).
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Figure 4. A diagram of the transfonnation of glutamate into GABA by the enzymatic
action of GAD.
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Relationship Between EAA and GAB A-A
The relationship between excitatory and inhibitory processes is complex. ACh is
closely associated with GABA, and GABAergic inhibition decreases ACh levels. The
mechanism involved in the ACh-GABA relationship is poorly understood, but it is
believed to be mediated via GABA receptors on cholinergic neurons (DeBoer &
Westerink, 1 994). GABA and muscimol (a GABA-A agonist) enhance cholinergic release
and this effect is blocked by biciculline (a GABA-A antagonist), indicating that the
GABA-A receptor complex plays a modulatory role in ACh release (Supavilai &
Karobath, 1 985).
Group I metabotropic glutamate receptors (mGluRs) have been implicated in the
excitation of neurons in the CA l of the hippocampus. C lassified by their pharmacological
profiles, Group I mGluRs include mGluR I and mGluR5. The Group I mGluRs not only
excite neurons via depolarization by glutamate release, but they also play a role in
regulating GABA release. GABAergic intemeurons in the hippocampus are activated by
mGluRs either pre- or post-synaptically. Group I mGluRs increase neuronal excitation by
co-localizing on neurons which also contain GABAaRs. Group II mGluRs are located on
inhibitory terminals and act to reduce GABA release. In the CA l of the hippocampus,
Group I mGluRs modulate pyramidal cell input from GABAergic intemeurons.
Activation of Group I mGluRs on inhibitory intemeurons in the hippocampus contributes
to the overexcitation which is associated with epilepsy and may play other important roles
in disrupting the excitatory- inhibitory balance (Bordi & Ugolini, 1 999).
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As would b e expected b y the importance o f mGluRs in GABAergic balance,
NMDA-type glutamate receptors and GABAaRs are co-localized in hippocampal neurons
(Craig, Blackstone, Huganir, & Banker, 1 994). Modulation of NMDA glutamate
receptors by MK-80 1 antagonism decreases GABAaR-mediated Cl- uptake by 44% in the
hippocampus (Matthews, Dralic, Devaud, Fritschy, & Marrow, 2000). Stimulation of
GABAaRs has been shown to be protective against neuronal injury induced via NMDA
receptor activity. GABA-A agonists block NMDA-induced damage and this protection
can be reversed by GABA-A antagonists such as biciculline (Ohkuma, Chen, Katsura,
Chen, & Kuriyama, 1 994).
The GABA-A Receptor
The GABAaR is part of a superfamily of neurotransmitter-gated ion channels
which includes nicotinic ACh receptors, glycine receptors and glutamate receptors (Sigel

& Buhr, 1 997; Schwartz, 1 988). GABAaRs mediate the maj ority of CNS inhibitory
neurotransmission (Mohler et aI., 1 996). The fast-acting GABA-A ion channel reacts
within milliseconds to receptor activation by ligand-binding, initiating the opening or
gating of a Cl- channel (Stephenson, 1 995). GABAaRs help regulate anxiety, vigilance,
memory, convulsive activity and muscle tension (Mohler et aI ., 1 996). Although the
binding sites are distinct, through ligand-mitigated action they initiate complex
interactions with each other (Kandel, Schwartz, & Jessell, 1 99 1 ; Sieghart, 1 995). The
binding of one ligand increases the affinity for other ligands (e.g., benzodiazepine binding
increases receptor binding affinity for GABA). Activation of the GABA binding site
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produces a confonnational change in the receptor, increasing the binding capabilities of
other ligands and ultimately increasing CI- flux and neuronal hyperpolarization (Li,
Siegel, & Schwartz, 1 993 ; Lyden, 1 997; Sieghart, 1 995). GABAaR activation also
reduces glucose metabolism and mediates cerebral blood vessel dilation, improving blood
flow (Lyden, 1 997).
GABAaR Subunits
The GABAaR has a pentameric structure (Lyden, 1 997). The heterogeneity of the
fonnation of the receptor by its constituent subunits has prompted it to be referred to as a
"heterool igomeric complex" (Matthews et aI., 2000; Backus et aI ., 1 993), which is a
common subunit composition for ligand-gated ion channels (Backus et aI., 1 993). Five
subunits, each with several isofonns have been identified, including:
P I -3

a l �'

PI-4' Y 1 -3 ' 0, and

(Luddens & Wisden, 1 99 1 ; Pritchett, Luddens, & Seeburg, 1 989a; Pritchett et aI.,

1 989b; Schofield, 1 989; Sieghart, 1 995; Smith & Olsen, 1 995). Each subunit is encoded
by a different gene (Sieghart, 1 995), and contains both a hydrophilic NH2 (N) tenninal
and a cystine (C) tenninal domain. Subunits consist of four transmembrane helices (M I 
M4) and a large intracellular loop located between M3 and M4 (Burt & Kamatchi, 1 99 1 ;
MacDonald, Saxena, & Angelotti, 1 996; Olsen & Tobin, 1 990). The N-tenninal lies
between the M l and M3 domains and the M2 domain lines the inside of the Cl- channel
(Kandel, Schwartz, & Jessell, 1 99 1 ; Stephenson, 1 995). The M2 domain is positively
charged and believed to be responsible for anion selectivity of the CI- pore (Kandel,
Schwartz, & Jessell, 1 99 1 ).
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Each type o f subunit (e.g., a and P ) shares 30-40% o f their amino acid sequence.
Within a subunit type, the different isoforms (e.g., a l and (2) have 70% identical amino
acid sequences. Amino acid GABAaR sequences are conserved approximately 90%
across mamm alian species (Stephenson, 1 995). Each type of subunit is distinctively
different in its encoded sequence and its function. However, due to the similarity between
the subunit constituent sequences, changes to a single amino acid residue can drastically
change receptor stoichiometry and binding properties (Buhr & Sigel, 1 997). Although
recombinant receptors containing one, two, three, four, or five subunits have been
identified, the most common form in vivo contains three subunits (Persohn, Malherbe, &
Richards, 1 992; Wisden et ai., 1 992). Of the five identified subunits, a, p, and y are
considered the "main" subunit types, while 0 and
(Lyden, 1 997; Mohler et ai., 1 996). The 0 and

p

p

are considered "minor" subunit types

subunits are considered minor because

they are rare and not widely distributed. The remaining three subunits (a, p, and y) have
several isoforms, each of which combines to form a wide array of receptor types.
GABAaRs with specific subunit combinations confer specific functions and distributions
within neuronal tissue. The most abundant subunits are a I , a2, a3, P2, P3, and y2
(Stephenson, 1 995).
GABAaRs with apy subunit combinations are the most widely distributed type
receptor type and this combination is important for proper benzodiazepine (BZ) binding
(Sieghart, 1 995). The most abundant GABAaRs in the rat brain consist of 2a, 1 p and 2y
subunits, although 2a, 2P, and 1 y is also a common subtype (Backus et ai., 1 993) (See
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Table 3). Specific brain regions, such as the hippocampus, contain more or less abundant
populations of GABAaR subtypes. One of the most expressed receptor subtypes in the
hippocampus is a2p3y2, although in other areas of the brain the a I P2y2 GABAaRs are
most abundant (Sieghart, 1 995). Overall, 75% of all GABAaRs are made up of three
receptor subtypes: a 1 P2y2, a2p3y2, and a3 p3y2 (Mohler et aI., 1 996).
The relative abundance of subtypes and heterogenous clustering of certain types of
receptors in different brain areas has increased the understanding of the role that each
subunit plays in the overall function of the GABAaR. The binding site for BZs lies on the
y subunit at the a junction (Sieghart, 1 995) (See Figure 5). The BZ binding site location
determines its function, indicating that although a contributes to binding specificity, the
presence of either y2 or y3 is required for proper BZ action (Luddens, Korpi, & Seeburg,
1 995; Persohn, Malherbe, & Richards, 1 992; Somogyi, Fritschy, Benke, Roberts, &
Sieghart, 1 996; Stephenson, 1 995; Wisden et aI, 1 992). The widespread action of BZs
may be explained by the relative abundance of y2 subunits (40-50% of GABAaRs) in rat
brains (Benke, Mertens, Trzeciak, Gillessen, and Mohler, 1 99 1 ). Similarly, the GABA
binding site's location on the p subunit explains the presence of p in nearly every known
receptor subtype. Since the GABA binding site is near the ap junction (Refer to Figure 5),
it also follows that a plays an important role in GABA binding affinity, although this

57

Table 3 . The characteristics of each of the known subunits of the GABAaR.
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Figure 5. A diagram of a common composition of the GABAaR identifying GABA and
BZ binding sites.
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remains to be definitively determined (Huh, Delorey, Endo, & Olsen, 1 995; Huh, Endo,

& Olsen, 1 996; Stephenson, 1 995).
Modulation of the GABAaR by Ligand Binding
The numerous binding sites on the GABAaR translate into complex
pharmacological potential. Modulation of the GABA-B receptor does not show
neuroprotection in ischemia (Araki, Kato, & Kogure, 1 99 1 ; Ito, Watanabe, Isshiki, &
Uchino, 1 999). GABAaR agonists, however, have consistently demonstrated their
effectiveness in several types of CNS insults (Arika et aI., 1 993 ; Cross et aI., 1 99 1 ;
Inglefield, Wilson, & Schwartz-Bloom; Ito et aI ., 1 999; Johansen and Diemer, 1 99 1 ;
Matthews et aI ., 2000; O'Dell and Hamm, 1 995; O'Dell et aI., 2000; Schwartz et aI. ,
1 994; Schwartz-Bloom e t aI., 1 998; Shauib and Kanthan, 1 997; Wahlgren, 1 997) while
antagonists are likely to exacerbate injury-related deficits (Hernandez, Heninger, Wilson,

& Gallager, 1 989; Ito et aI., 1 999; O'Dell et aI ., 20000; Ohkurna et aI., 1 994).
Although GABAaR binding sites interact, they have unique pharmacological
qualities, and some provide greater neuroprotection than others against CNS injury.
Barbiturates such as pentobarbital are ineffective in preventing neuronal degradation
following ischemia (Araki, Kato, & Kogure, 1 99 1 ; Ito et aI., 1 999). Partial GABA-A
agonists such as Ro 1 6-6028 and imidazenil show l imited protection in ischemia
(Hernandez et aI., 1 989; Schwartz-Bloom et aI ., 1 998). Drugs that act to increase GABA
(muscimol) or prevent GABA-T from removing GABA from the synapse (gamma-vinyl
GABA, No-328) also provide effective neuroprotection after injury (Ito et aI ., 1 999;
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Johansen & Diemer, 1 99 1 ; Katoh, Shima, Nawashiro, Wada, & Chigasaki, 1 998; Shauib

& Kanthan, 1 997; Wahlgren, 1 997). Other GABAaR modulators such as chlormethiazole
and MDL 26,479 (Suritozole) are at least partially neuroprotective (Cross et ai., 1 99 1 ;
Fujisaki et ai., 1 999; Johansen & Diemer, 1 99 1 ; Shauib & Kanthan, 1 997; Wahlgren,
1 997). The most widely used and most demonstrably effective drugs in neuroprotection
are the benzodiazepines (BZs), diazepam (DZ) in particular. DZ has consistently
demonstrated its effectiveness in providing neuroprotection following CNS insult
(Hernandez et ai., 1 989; Inglefield et ai., 1 997; Johansen & Diemer, 1 99 1 ; O'Dell et ai.,
2000; Schallert, Hernandez, & Barth, 1 986; Schwartz et ai., 1 994; Schwartz-Bloom et ai.,
1 998; Sigel et ai., 1 990). Working memory enhancement (Moran, Kane, & Moser, 1 992)
and cognitive deficit attenuation following TBI (O'Dell et ai., 2000) have also been
attributed to DZ treatment.
Benzodiazepines such as DZ bind to the GABAaR, instigating a conformational
change that allows GABA to bind more readily and more tightly. Increased GABA
stimulation of the receptor increases the potency and frequency of Cl- channel opening.
Each receptor may have a BZ binding site located on each of the constituent y subunits,
and an additive effect may occur when combined with barbiturates or GABA agonists.
The presence of GABA is required for proper BZ action (Kandel, Schwartz, & Jessell,
1 99 1 ; Sieghart, 1 995).
Immunoreactivity in the Hippocampus
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The hippocampus has been well-characterized with regards to GABAergic
immunoreactivity (IR). Anti-GAD and anti-GABA antibodies have demonstrated that
dendritic fields and intemeurons in the CA 1 , CA3 and hilar regions of the hippocampus
are GABAergic (Garnrani, Onteniente, Seguela, Gefferd, & Calas, 1 986; Nishikawa,
Takahashi, & Ogawa, 1 994; Terai, Tooyama, & Kimura, 1 998; Woodson, Nitecka, &
Ben-Ari, 1 989). GABA and GABAaR staining are not always co-localized, however. The
neurotransmitter GABA is likely to be found in the nucleus, cytoplasm and in the
synapses, especially of the intemeurons (Gamrani et aI., 1 986; Somogyi et aI., 1 996;
Terai, Tooyama, & Kimura, 1 998). Subunit-specific antibodies that stain the GABAaR
demonstrate that GABA-A is most often located along the membranes of somata and on
the axonal and dendritic processes (Gao & Fritschy, 1 994; Inglefield, Wilson, &
Schwartz-Bloom; Li, Siegel, & Schwartz, 1 993; Mizuhami et aI ., 1 997; Somogyi et aI .,
1 996; Terai, Tooyama, & Kimura, 1 998). In an in situ hybridization characterization of
ex l and P2 in the hippocampus, Li, Sigel and Schwartz demonstrated in 1 993 that
GABAaR subunits reside predominantly on non-pyramidal cells. y2 subunits, which tend
to co-localize with ex l and P2 or P3, are highly expressed in dendritic layers and on
intemeurons (Somoygi et aI., 1 996).
One of the best-known and most often used antibodies in GABAaR
immunohistochemical staining is bd 1 7 (Boehringer Mannheim), which recognizes both
GABAaR P2 and p3 (P2/3) subunits (Benke et aI., 1 99 1 ; Ewert et aI. , 1 990; Pesold et aI.,
1 997). The least expressed of the p subunits is P I (Stephenson, 1 995). Although all p
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subunits are present in the hippocampus, P I IR is rare and p3 is much less abundant than
P2 (Huh et ai., 1 995). Since p subunits are important for GABA binding and have been
found in nearly all GABAaR types in vivo (Stephenson, 1 995), the bd 1 7 antibody is
likely to stain nearly all of the GABAaRs in the hippocampus. Development of P2- and
P3- isofonn-specific antibodies has introduced difficulties not found in other subunit
types. The P2 and p3 subunits both lie within the 50-58 kDa weight range (Matthew et ai .,
2000). To further complicate matters, the p intracellular loops are identical and p subunits
do not have the hydrophilic C-tenninus which is present in other subunits (Stephenson,
1 995).

Chapter IV: Acute GABA-A Receptor Modulation by Diazepam Following
Traumatic Brain Injury in the rat: An Immunohistochemical Study

Introduction
As demonstrated in the previous chapter, inhibitory agonists are effective in
counter-acting ischemia-induced excitotoxicity. Although ischemia and TBI produce
similar inj uries, there are some important differences (see Chapter II). It is unknown
whether treatments that show neuroprotection in ischemia will be effective in attenuating
TBI-induced deficits.
Although the primary focus in acute TBI treatment has been to reduce excessive
neuroexcitation, restoring the normal excitatory/ inhibitory balance by increasing
inhibition may also be beneficial. In a model of mild weight drop-induced closed head
injury followed by hypoxia, Katoh et al. ( 1 998) measured glutamatergic and GABAergic
changes in the hippocampus using microdialysis and autoradiography methods.
Elevations in glutamate and GABA were observed in the CAl and CA3 regions of the
hippocampus. Autoradiography revealed increased binding to NMDA-type glutamate
receptors and decreased binding of muscimol to GABAaRs in the CA I at 1 and 24 hours
following ischemia (Katoh, Shima, Nawashiro, Wada, & Chigasaki, 1 998). Increased
glutamatergic and decreased GABAergic binding in the hippocampus during the first 24
65
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hours following injury indicates a disruption in excitatory/ inhibitory homeostasis may be
occurring.
The hippocampus, which is selectively vulnerable to TBI, may be better able to
maintain an appropriate excitatory/ inhibitory balance post-injury if the overexcitation of
neurons is attenuated by increasing GABAergic neurotransmission. O' Dell ( 1 99S)
investigated three GABAaR agonists following moderate FPI in rats. Although little
benefit was found following muscimol or midazolam treatment, pre-inj ury injections of S
mg/kg of diazepam effectively attenuated TBI-induced morris water maze (MWM)
deficits. Using anti-GABA antibodies, O'Dell ( 1 99S) also found that DZ significantly
increased GABA-positive IR in the hippocampus 24 hours following TBI. Cognitive
deficits and cell loss following ischemia, which produces a similar excitotoxic pathology,
have also been shown to be attenuated by DZ and other inhibitory agonists.
Although the specific mechanism mediating various behavioral effects of
GABAergic drugs is unknown, stimulation of GABA-induced CI- channel opening by DZ
during the acute phase of TBI may help to reduce excitotoxic damage. Acute DZ
treatment has been shown to attenuate TBI-induced MWM deficits in a study of central
FPI in rats. The central FPI produces a diffuse inj ury with sublethal morphological
alterations. Both pre- and post- injury DZ (Smg/kg) treatment effectively attenuated TBI
induced MWM deficits I S days following TBI in rats. The benefits of GABAaR agonist
activity by DZ were in direct contrast to the exacerbation of deficits by administration of
the GABAaR antagonist biciculline (O' Dell et ai., 2000). Although 1 0 mg/kg is the
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standard DZ dose for ischemia (Inglefield, Wilson, & Schwartz-Bloom, 1 997; Li, Siegel,

& Schwartz, 1 993; Schwartz et aI., 1 994), this dose has not been found effective in
attenuating TBI-induced deficits (O' Dell, 1 995). However, 5 mglkg has been shown to be
effective in TBI, without significantly lowering brain temperature (O'Dell et aI., 2000).
DZ has been shown to be neuroprotective when administered within 72 hours following
ischemia in the rat (Johansen & Diemer, 1 99 1 ) and up to four hours following ischemia in
the gerbil (Schwartz et aI., 1 998). In TBI, 5 mglkg DZ was equally effective in cognitive
attenuation when administered either 1 5 minutes prior to or 1 5 minutes following FPI
(O' Dell et aI., 2000).
Cognitive deficits following injury may be preceded by morphological changes in
selectively vulnerable areas such as the hippocampus. Ischemia literature has shown that
a l and P2 mRNA decreases in the CA l , CA3 and DG of the hippocampus by four hours
following reperfusion. mRNA returns to normal in the CA3 and DG by twelve hours,
although the CA l continues to decrease steadily over the next three days, ultimately
decreasing by 85% of normal values. The CA3 and DG do not characteristically show
changes following ischemia, whereas, the CA 1 region shows delayed degeneration and
cell death by four days post-injury (Li, Siegel, & Schwartz, 1 993). GABAaR a 1 subunit
immunoreactive changes do not become apparent until three to four days following
ischemic insult, coinciding with cell loss in the CA 1 (Inglefield, Wilson, & Schwartz
Bloom, 1 997).
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The pathological morphology of ischemia is likely to differ from other types of
CNS insults. In a study of TBI in the rat, Reeves et al. ( 1 997) found that two days post
inj ury population spike inhibition was reduced in the CA3 commissural pathway to the
CA 1 and GABAergic immunobinding increased in the SLM and SP layers of the CA 1 .
Perforant pathway lesions produce changes in interneurons positively labeled for P2/3
subunits in the molecular layer of the DG by 24 hours post-lesion (Mizukami et aI.,
1 997). In TBI, changes in neurons stained with anti-GABA antibodies also become
apparent by 24 hours following inj ury (O'Dell, 1 995). The 24 hour time point allows
initial impact depolarization and excessive neurotransmitter changes to occur, but still
falls within the acute time period for TBI in rats. The excitatory/ inhibitory ratio is likely
to be disrupted and changes in receptor binding (Katoh et aI., 1 988) and GABAergic
immunoreactivity (O' Dell, 1 995 ; Reeves et aI., 1 997) are evident.
GABAaRs are present on nearly all CNS neurons and mediate the majority of
inhibition. Changes in GABAergic neurotransmission following injury would indicate
that receptor changes may also occur. Changes in GABAaR a; 1 subunits in the CA 1 have
been demonstrated following ischemia (Inglefield, Wilson, & Schwartz-Bloom, 1 997)
and sub-laminar-specific changes in P2/3 subunits in the molecular layer of the DG have
been found following perforant pathway lesion (Mizukami et aI., 1 997). It would follow
that TBI-induced GABAaR changes may also occur.
Since the bd 1 7 antibody has been shown to specifically stain the P2/3 subunits of
the GABAaR (Matthew et aI., 2000) and since P subunits are constituent parts of all
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known GABAaRs, it would follow that the bd 1 7 antibody would stain virtually all of the
GABAaRs in the hippocampus (p 1 is rare in the hippocampus - See Chapter III).
The current study was designed to further investigate the role of inhibition
following TBI. GABAaR IR may be altered following FPI and acute treatment with DZ
should attenuate these alterations. Injury-induced changes in GABAaR P2/3 subunit IR
were expected 24 hours following TBI, since GABAergic changes have previously been
documented for this time point (O' Dell, 1 995).
Methods
Subjects
Adult male Sprague-Dawley rats were divided into four groups of 5 animals (4
groups x 5 animals = 20 animals total): sham/vehicle, shamlDZ-treated, injured/vehicle,
and inj uredIDZ-treated. The number of subjects per group was chosen because previous
immunohistochemical studies have found 4-5 animals to be sufficient for statistical
significance (Inglefield, Wilson, & Schwartz-Bloom, 1 997; Li, Siegel, & Schwartz, 1 993;
Neumann-Haefelin et aI., 1 998). Animals were individually housed in a vivarium on a
1 2 : 1 2 hour light/dark cycle and received food and water ad libitum.
Pharmacological Manipulation
Diazepam (5 mg/kg) was obtained from the local hospital pharmacy and
administered to animals in one bolus injection (intra-peritoneal) 1 5 minutes prior to injury
or sham-injury. This dose has been shown to be effective in attenuating cognitive deficits
in the MWM without significantly altering MABP or brain temperature after injury
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(O'Dell et aI., 2000). The pre-injury injection was chosen as appropriate for analyzing
morphological changes to the GABAaR following inj ury. Also, no significant differences
were found in cognitive endpoints between pre- and post-injury injections. The pre-injury
injection did, however, attenuate immediate post-injury mortality (O'Dell et aI., 2000).
Surgical Preparation
Subjects were surgically prepared under sodium pentobarbital (54 mg!kg), 24
hours prior to inj ury. While under anesthesia, animals were placed in a stereotaxic frame
and a sagittal incision was applied to the scalp. A craniotomy hole was made over the
central suture, midway between bregma and lambda. Burr holes were drilled to hold two
nickel plated screws (2-56 x 6

rom

) 1

rom

rostral to bregma and 1

rom

caudal to lambda

along the central suture. A modified Leur-Loc syringe hub (2.6 rom interior diameter) was
placed over the exposed dura and sealed with cyanoacrylate adhesive. Dental acrylic was
applied over the entire device (leaving the hub accessible) to secure the hub to the skull.
The incision was sutured and bacitracin applied to the wound. Animals were kept warm
and continuously monitored until they had fully recovered from the anesthesia. Upon
recovery, animals were returned to the vivarium where food and water were available.
Fluid Percussion Injury
The fluid percussion inj ury device has been described in detail elsewhere (Dixon
et aI., 1 987; McIntosh, Noble, Andrews, & Faden, 1 987) and is shown in Figure 6.
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Figure 6 . A picture of the fluid percussion injury device.
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Briefly, a Plexiglass cylinder 60 cm long and 4.S cm in diameter is filled with saline. A
rubber-covered piston at one end of the device is mounted on O-rings. On the other end,
metal housing contains a pressure transducer (Entran Devices, Inc., model EPN-0300*1 00A). A S-mm syringe with an interior diameter of 2.6

mm

terminates in a male Leur

Loc vehicle is located on the end of the pressure transducer. The male fitting is connected
to the modified female Leur-Loc hub implanted over the open dura of the rat. A metal
pendulum (4.S4 kg) is released from a pre-determined elevation, impacting the piston of
the injury device. The impact delivers a pressure pulse through the continuous water
filled cylinder into the closed cranium of the rat. Brief displacement and deformation of
brain tissue results and the pressure pulse is measured by the pressure transducer in
atmospheres (atm) and displayed on a storage oscilloscope (Tektronix S i l l : Beaerton,
OR).
Animals were anesthetized under 4% isofluorane in a carrier gas consisting of
70% Np and 30% O2 , twenty-four hours following surgical preparation. The previous
incision was re-opened and the animals were connected to the fluid percussion device via
the female-to-male connection described above. Animals in the injury groups received a
moderate fluid pulse (2. 1

±

. 1 atm). Sham animals were attached to the injury device but

no fluid pulse was delivered. The incision was sutured and bacitracin was applied.
Neurological assessments including cornea, pinnae, toe, tail and righting reflexes were
monitored. The animals were closely monitored until they had sufficiently recovered and
were then transferred back to the vivarium where food and water was available.
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GABAaR Immunohistochemistry
Twenty-four hours following inj ury, brain tissue was fixed via cardiac perfusion.
A solution of 4% paraformaldehyde and 1 5% of a solution of picric acid in 0. 1 M
phosphate buffer followed a 50 mL rinse with PBS. Immediately following perfusion, the
brain was removed and placed in the paraformaldehyde solution for three hours. Blocked
sections, 1 0 to 1 5 mm thick, were incubated overnight in a 0. 1 M citric phosphate buffer,
pH 4.5. The blocked sections were then boiled in the same solution in a 650 Watt
microwave oven for two to three minutes. After the tissue cooled, it was incubated in
PBS containing 1 0% Dimethyl Sulfoxide (DMSO) (Sigma) for three hours.
Consecutive coronal vibratome sections (40 f.Lm thick) were taken from the mid
dorsal hippocampus. Four mid-dorsal sections per animal, 200 f.Lm apart, were selected
and incubated overnight at room temperature in primary antibody solution. The GABAaR
P2/3 specific antibody bd 1 7 (Boehringer Mannheim) was diluted 1 :500 in Tris-saline (pH
7.4), as determined by preliminary concentration tests. Normal serum (2%) made in horse
(anti-mouse) was added to the primary antibody incubation solution. Sections were then
rinsed 3 x 1 0 minutes in 50 mM Tris-saline buffer with 0.05% Triton X- I 00, pH 7.4.
Rinsed sections were incubated in biotinylated antibody (anti-mouse) diluted in a 50 mM
solution of Tris-saline, pH 7.4 for 30 minutes at room temperature. Following the
incubation period, tissue was rinsed 3 x 1 0 minutes in Tris-saline with Triton and
incubated for 1 5-20 minutes in ABC Reagent (Vector ABC Kit). Then, sections were
washed 3 x 1 0 minutes in Tris-saline with Triton and incubated in 0. 1 % 3 ,3'-
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diaminobenzidine dihydrochloride (DAB) diluted in 50 mM Tris-saline, pH 7.7. The
reaction took place in a Tris-saline solution (PH 7.7) containing 0.05% DAB, 0.2% nickel
(II) sulfoxide, 2% P-D-glucose, 0.04% ammonium chloride and 0.0005% glucose oxidase
(Sigma, type VII). The reaction was stopped by a quick rinse in Tris-saline, pH 7.4 at 4°C.
Sections were washed 3 x 1 0 minutes in Tris-saline with Triton and mounted on gel
coated slides. This procedure was selected for use based on reports that it can decrease
background staining and enhance details of immunostained GABAaRs (Fritschy et aI.,
1 996). One of the unique features of the immunohistochemistry (IHC) method described
above is the microwave antigen retrieval. This method was shown in preliminary studies
to be effective in reducing background and increasing the signal-to-noise ratio. Tissue
shrinkage which may occur due to boiling should be uniform across groups, since all
sham and inj ured tissue was subjected to the same protocol. Detailed
immunohistochemical protocols are available at
www

.unizh.ch/phar/neuromorpho/Protocois.htm. The final visualization process used

was modified from the original protocol, utilizing glucose oxidase rather than peroxide to
drive the reaction. Preliminary studies indicated that the glucose oxidase reaction was
longer-lasting and produced more consistent results than peroxide.
Image Analysis
The hippocampal CA I and CA3 sectors were examined for the presence of
GABAaR-IR cells. The C A l region was chosen based upon data presented in the
ischemia literature, which shows selective vulnerability in this area. Also, GABAergic
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changes have been found in specific laminae of the CAl following TBI (O' Dell, 1 995).
The CA3 region was chosen for analysis because of its potential for change following
TBI and since qualitative observations in preliminary studies indicated inj ury-induced
changes in this area. GABAaRs primarily stained pyramidal and interneuron dendritic
processes, ruling out the possibility of counting cell bodies (profile count). Due to the
non-uniform orientation of the dendrites and the variation in staining intensity, standard
optical density measures (relative optical density x area) were not a viable option for
analysis. For these reasons, number and length of IR dendritic processes in three laminae
of the CAl and CA3 fields, including the pyramidal cell layer, SR and SLM were
quantified. The SO layer was not included because it was too densely stained to
effectively assess individual processes and no qualitative differences were observed in
that layer. The remaining three layers (pyramidal cell, SR and SLM) were analyzed by an
MCID image analysis system, which was calibrated specifically for the 20x objective
used to capture the images.
Sections included in the analysis were coronal slices (2-3 per animal), separated
by a minimum of 200 �m. These sections were from the mid-dorsal hippocampus and
were analyzed in both the C A l and CA3 regions (see Figure 7). Since the central FPI
does not show significant morphological differences in the hippocampal formation
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Figure 7. A picture of the mid-dorsal hippocampus of a sham animal immunolabeled with
the bd l 7 antibody. Areas in red boxes represent C A l and CA3 regions selected for
analysis.
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between hemispheres, only one hippocampus (randomly chosen) was analyzed per tissue
section .. Images were captured at 20x magnification, and were then enlarged by 50% in
the CA3 in order to allow for a representative cross-selection of the SP, SR, and SLM
fields. Due to the increased length of the CAl apical dendritic trees in the above
mentioned layers, images were enlarged 33%. The image magnification and sample area
were held constant for all sham and injured groups. Each IR process within the pre
designated area was traced, allowing for the analysis of both number and length of
processes. In order to insure random sampling of stained tissue, all visible processes had
an equal chance of inclusion (Coggeshall, 1 999). Since the width of individual dendrites
varied due to proteins embedded in the membrane, processes were traced along the
external edge of one side, following the contours of the process (see Figure 8). The area
of analysis was standardized per 1 0,000 Iim2 to account for group differences and
potential variation in area demarcation. Since inj ury may result in shrinkage of tissue, in
order to determine that changes were due to injury-induced alterations rather than a
change in the reference space itself (Coggeshall & Lekan, 1 996), CA 1 sham and injured
lamina were measured and compared. Inj ured tissue was slightly shrunken in the SR and
SLM layers (0.4%) and in the SP layer (7.5%). The majority of IR processes were
analyzed in the SR and SLM layers, therefore, injury-induced alterations between sham
and inj ured tissue in excess of 0.4% were considered valid. The mean length and number
of processes for each animal were obtained for both the CA 1 and CA3 regions by first
averaging the tissue section results for each subject and then analyzing group differences.
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Figure 8. An enlarged example ( 1 00%) of an analyzed CA3 dendrite (captured at 20x
magnification). The red line is an example of a measurement of the distribution of
GABAaRs along the length of the dendrite, following the outer contours of the process.
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Statistical Analysis
The study was arranged as a 2 x 2 completely randomized design. The two
variables were inj ury level (inj ured or sham) and drug treatment (saline or 5 mglkg OZ).
A Chi-Square test of homogeneity was used to analyze mortality rates between groups.
Two factor ANOVAs were used to analyze potential injury and treatment differences in
number and length of IR processes in both the CA 1 and CA3 regions. The number of
processes were analyzed by number per 1 0,000 square IJ.m to account for potential
differences in areas selected for analysis. A simple effect analysis was used to compare
groups when interaction effects were found and a significance level of p<.05 was used for
all tests.
Results
Post-Injury Reflexes
A two-way ANOV A (inj ury x treatment) indicated that injury significantly
suppressed reflexes. Toe pinch (measured in minutes), was suppressed in injured groups
(M

=

4.974) compared to sham groups (M

=

1 .885), F

( 1 . 1 5)

=

5 .506, P < .05. Corneal

reflex (measured in minutes) was also suppressed in injured groups (M
compared to sham groups (M

=

1 .780), F ( 1 .

15) =

=

6.43 1 )

8.084, P < .05. Neither the toe pinch nor

the corneal response, both of which are simple reflexes, demonstrated significant
treatment effects. The more complex righting reflex (measured in minutes) was delayed
following injury (M

=

24.682), compared to sham groups (M

=

6.444), F ( 1 . 1 5 ) = 3 1 .785, P

< .000 1 . The pre-injury injections also produced significant suppression of reflexes for
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DZ-treated (M

=

23.602) compared to saline-treated (M

=

5 .6 1 8) animals, F ( 1 . 1 5 ) =

33.852, p < .000 1 . A significant interaction was found between injury and treatment
groups for righting latency, F ( I . 1 5 ) = 5 .276, P < .05. A simple effects analysis revealed that
saline-treated groups had significantly longer righting latencies following injury (M =
1 1 . 1 78) than following sham treatment (M = 1 . 1 70), F ( 1 . 7 ) = 6 . 1 89, P < .05. DZ-treated
animals also had delayed righting latencies following injury (M = 35 .486), compared to
sham treatment (M = 1 1 .7 1 8), F

( 1 , 8) =

29.605, P < .0 1 . Although both saline-treated and

DZ-treated animals demonstrated significant injury effects on righting reflex, DZ
extended the righting latency in both inj ured and sham animals. Therefore, although pre
injury DZ treatment did not significantly effect simple reflexes, the more complex
righting response was altered due to treatment.
Mortality Rates
Mortality rates for animals in each group are shown in Table 4. A Chi-Square test
of homogeneity revealed a marginally significant difference in mortality between groups,
2
X (3, !:! = 22)

=

7.444, P = .059. The only group that experienced mortality over the course of

this experiment was the inj ured-saline group (43% mortality). DZ effectively prevented
injury-related death (0% mortality). The primary cause of mortality in injuredlsaline
treated animals was pulmonary edema.
Qualitative Tissue Evaluation
As expected, GABAaR P2/3 subunit IR was located primarily in the dendritic
processes of pyramidal cells and intemeurons. In the hippocampus proper, the SP layer
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was mostly devoid of staining, although the membranes of some pyramidal cell somata
were IR. Positively labeled receptors were extremely dense in the SO layer, and the SR
and SLM layers were also heavily stained. In the DG, only the molecular layer showed
discemable IR, although it was not as profusely labeled as the dendritic layers of the
hippocampus proper (See Figure 9).
Evaluation of processes in the CA3 region revealed pervasive dendritic
segmentation and an overall reduction in stain quality in injured/saline-treated animals
compared to shamlsaline-, shamlDZ-, and injuredIDZ-treated groups (See Figure 1 0). The
appearance of segmental beading (varicosities) along processes was specific to the
injured/saline group and was only found in the CA3 region.
GABAaR Distribution in CA 1 Dendritic Processes
Although inj ury-induced alterations were expected in the CAl of the
hippocampus, two factor ANOVAs (injury x treatment) did not reveal a significant injury
effect on number (F

( 1 . 9)

=

0 . 1 54, p > .05) or length (F

( 1 , 9)

=

0.027, P > .05) of GABAaR

P2/3 IR dendrites (see Figure 1 1 for photomicrographs of the CA 1 ) . Since no significant
inj ury-induced changes were found, alterations could not be attenuated by DZ, and
treatment effects were not revealed for either number (F ( 1 , 9) = 0,004, P > .05) or length of
IR dendritic processes (F ( 1 , 9) = 0.0 1 5, p > .05). Also, no significant interaction effect for
number (F ( ! . 9 ) < 0.00 1 , p > .05) or length (F ( I , 9) = 0.242, P > .05) of processes were found
in the CAL Collectively, these analyses indicate that no significant GABAaR P2/3
subunit alterations are evident in the CA 1 region of the hippocampus 24 hours following
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TBI. Figure 1 2 shows the mean number and Figure 1 3 shows the mean length of IR
processes per group in the CA l region of the hippocampus.
GABAaR Distribution in CA3 Dendritic Processes
A two factor ANOVA (inj ury x treatment) revealed that the overall number of
dendritic processes in the CA3 was not altered by injury (F ( 1 , 10) = 0. 820, p > .05). Drug
treatment also did not significantly effect the number of processes in this region (F ( 1 , 10 ) =
1 .727, P > .05). An interaction effect between injury and treatment was not found (F ( 1 . 10 )
=

0.068, P > .05). Qualitative evaluation of the CA3 , however, indicated changes in this

region (see Figures 1 0 and 1 4). Figure 1 5 shows the mean number of CA3 processes per
group.
Although the mean number of dendrites in the CA3 was not significantly altered,
a two factor ANOVA (inj ury x treatment) revealed that TBI did significantly reduce the
length of P2!3 IR processes, F ( 1 . 1 0)
animals (M

=

=

37.4 1 8, P < .000 1 . The apical dendrites of injured

1 9.639) were significantly shorter than those of sham animals (M

=

22.772). Analysis also revealed that DZ attenuated these alterations in IR dendritic length,
F ( 1 , 10) = 3 1 .032, P < .000 1 . Dendritic processes in the CA3 were significantly shorter for
saline-treated animals (M = 1 9.822) than for DZ-treated animals (M
interaction between inj ury level and treatment effect was found, F ( I ,

=

10)

22.588). An
=

1 7.594, P < .0 I ,

and a simple effect analysis indicated that inj ured animals treated with saline (M

=

1 6.470) had significantly shorter CA3 dendritic processes than the injured animals treated
with DZ (M

=

22.0 1 5), F ( 1 . 5 ) = 57. 1 64, P < .0 1 . Sham animals did not significantly differ
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in CA3 dendritic length (F
=

22.337) or DZ (M

=

( 1 .5)

=

1 .2 1 3 , p > .05) whether they were treated with saline (M

23.352). Positively labeled GABAaRs along the dendrites of the

CA3 (lR length), therefore, was similar for all groups, except the injured/saline-treated
group, in which mean length was reduced (see Figure 1 6).
Discussion
The current study was designed to investigate potential alterations to GABAaR
P2/3 subunit IR in the hippocampus of rats 24 hours following TBI. The only injury
related alteration found was decreased length of IR dendritic processes in the CA3 region
of the hippocampus. The ' length' of the dendrite in this study refers to the IR distribution
of P2/3 proteins along the process. Positively labeled dendrites of the CA3 formed
varicose beading along their length. This response to injury was probably a sublethal
cytoskeletal rearrangement driven by a calcium-based mechanism which was induced by
excessive neuroexcitation. Restoration of an appropriate balance between excitation and
inhibition may be achieved by either decreasing NMDA-mediated excitation with an
antagonist (e.g., MK -80 1 ) or by increasing GABAergic inhibition with an agonist such as
DZ. Restoration of balance between excitation and inhibition in the hippocampus
attenuated injury-induced changes, including dendritic cytoskeletal alterations.
Surprisingly, there were no changes in the CA 1 region in number, length, or
appearance of IR processes between groups. There may be several reasons why no
qualitative or quantitative changes were found in this area. First, previously documented
changes in anti-GABA IHC 24 hours following TBI were found in the SLM layer but not
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Table 4. The mortality percentages per group. A chi-square test of homogeneity was not
2
significant, X (3 )

=

7.44, p > .05 .
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Group

Subjeds

Died

% Mortality

Sham/saline

5

0

0

ShamlDZ

5

0

0

Injured/saline

7

3

43

Inj uredIDZ

5

0

0

89

Figure 9. A representative photomicrograph of a hippocampus stained with the bd 1 7
antibody.
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Figure 1 0. Representative photomicrographs of hippocampal CA l sections 24 hours
following TBI (magnification

=

20x).

A = Sham/Saline
B
C
D

=

=

=

ShamJDZ-treated
Inj ured/Saline
InjuredIDZ-treated

No significant inj ury or treatment effects were found between groups on either number or
length of IR processes in the C A l at 24 hours following injury.

92

•
.

, '.

•

.
.,
'"'

�

i

•
�

.

.

t

.
.t- .

I

.
"

�
..

.,

.
'

.

. ,.

.

,

.
'

it..

" ',

�

.

93

Figure 1 1 . Mean IR number of processes (and S.E.M.) per group in the hippocampal CAl
region 24 hours following TBI. No significant treatment or injury effects were found for
number of CA 1 processes.
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Figure 1 2. Mean IR length of processes (and S.E.M.) per group in the hippocampal CAl
region 24 hours following TBI. No significant treatment or injury effects were found for
IR length of CA 1 processes.
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Figure 1 3 . Representative photomicrographs of hippocampal CA3 sections 24 hours
following TBI (magnification
A
B
C

=

Sham/Saline

=

ShamlDZ-treated

=

Injured/Saline

=

20x).

0 = Inj uredIDZ-treated

A: The sham/saline group had significantly longer CA3 processes than the injured/saline
group at 24 h. B: ShamlDZ-treated animals were not significantly different from
sham/saline animals in number or length of IR processes. C: The injured/ saline group
had significantly shorter processes than all other groups at 24 hours following injury.
Overall number of processes did not differ between groups. 0: InjuredIDZ-treated
animals had significantly longer processes than the injured/saline group. There were no
significant differences between the inj uredIDZ-treated group and the sham/saline or
shamlDZ-treated groups in number or length of processes at 24 hours following injury.
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Figure 1 4. Mean IR number of processes (and S.E.M.) per group in the hippocampal CA3
region 24 hours following TBI. No significant treatment or inj ury effects were found for
number of CA3 processes.
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Figure 1 5 . Mean IR length of IR processes (and S.E.M.) per group i n the hippocampal
CA3 region 24 hours following TBI. The injured/saline group had significantly shorter
processes than the injuredIDZ-treated, sham/saline, or sham/DZ-treated groups. No other
group differences were revealed.
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Figure 1 6. An enlarged (33%) example of beaded dendrites found in the hippocampal
CA3 region 24 hours following injury (40x magnification). Only the injured/saline group
demonstrated dendritic beading.
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the SR layer of the hippocampal CA l region (O' Dell, 1 995). GABAaR staining of
processes did not allow for recognizable laminar demarcation between the SR and SLM
regions, therefore, collapsing across lamina may have reduced the sensitivity of analysis.
This is unlikely, however, since no qualitative changes in number or appearance
of CA l processes were evident, and all quantitative counts were extremely close between
all groups (refer to Figures 1 1 , 1 2 and 1 3). Another reason for lack of alterations in the
CA 1 may be that the 24 hour time point was not sensitive to changes in GABAaR IR.
Receptor changes may be delayed, as in ischemia, or may already have normalized by 24
hours. This is also unlikely, however, since GABAergic changes have been documented
with anti-GABA IR in the CA l at 24 hours (O'Dell, 1 995). A third possibility, which is
the most likely explanation, is that P2/3 protein expression was not altered in the CA 1 24
hours following injury.
Although the length of IR processes in the CA3 region was altered following
injury, the number of processes were not significantly different between groups. The
number of processes in this area may have been artificially inflated due to extensively
varicose and segmented dendritic appearance. This would, however, only have affected
the injured! saline-treated animals since varicosities were not found in any other group.
Similar findings have been demonstrated in CA 1 dendrites stained with GABAaR a 1
antibody following ischemia. Although processes were found to be beaded ("string of
beads"), the overall number of processes did not differ between ischemia and control
groups (Inglefield, Wilson, and Schwartz-Bloom, 1 997).
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Significant decreases in IR dendritic length were found in the CA3 of the
hippocampus for the injured-saline group. There may be several explanations for this
finding. TBI-induced impact depolarization is followed by a surge of synaptic release of
neurotransmitters, including GABA (Selzer, 1 995). Post-injury GABAaR down
regulation may occur due to excessive activation, altering expression preferentially in the
distal portions of dendrites. Alternatively, the number of receptors may remain constant
but the conformation of the receptor may be altered. Conformational alterations may
result in decreased expression of some subunits and increased expression of others. The
differential expression of these subunits may be due to altered subunit composition of the
GABAaR or a positional alteration that unmasks certain subunits more than other
subunits. There was, however, no change in the number of P2/3 IR processes and
differential subunit expression does not sufficiently account for the reduction in length of
CA3 apical dendrites.
Another explanation may be dendrotomy, which refers to the complete separation
of the proximal and distal portions of the dendrite. Axotomy has been well documented
following TBI (Maxwell, Wyatt, Graham, & Gennarelli, 1 993; Povlishock, 1 992;
Povlishock, Becker, Cheng, & Vaughan, 1 983; Yaghmai & Povlishock, 1 992). In DAI,
compaction of cytoplasm and neurofilaments occurs, producing pathologically altered
axonal transport (Povlishock, 1 992; Yaghmai & Povlishock, 1 992). Eventually, the
buildup of molecular material in the axon forms a retraction ball that separates from the
remaining distal portion of the axon (Povlishock et aI ., 1 983; Yaghmai & Povlishock,
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1 992). Ultrastructural changes have been documented for dendrites as well

as

axons

(Posmantur et aI ., 1 996; Posmantur et aI., 1 997; Saatman, Graham & Mcintosh, 1 998).
Immunolabeling of neurofilaments (NF68 and NF200) and microtubule associated protein
2 (MAP2), which is only found in somata and dendrites, revealed cytoskeletal protein
alterations in the apical dendrites of cortical pyramidal cells 3 and 24 hours fol lowing
lateral CCI (Posmantur et aI., 1 996; Posmantur et aI., 1 997). Fragmented swellings of
microtubule and neurofilament IR were also found in the CA3 region of the hippocampus
and in the DG 24 hours following lateral FPI in the rat (Saatman, Graham & Mcintosh,
1 998). In both models of TBI, microtubule and neurofilament fragmentation within
dendrites occurred in areas remote from the injury site and did not always precede cell
death, indicating that these changes may represent a sublethal cytoskeletal disruption
(Posmantur et aI., 1 996; Saatman, Graham, & Mcintosh, 1 998). Unlike injury-induced
axotomy, dendritic varicosities and alterations are more likely to be associated with
sublethal cytoskeletal rearrangements than with complete separation of proximal and
distal dendrites. Therefore, alterations in TBI-induced CA3 apical dendritic length are
probably not due to dendrotomy. Retraction of dendrites from degenerating pre-synaptic
neurons has been well documented in the DG following deafferentation of the perforant
pathway (Mizukami et aI., 1 997; Nitsch & Frotscher, 1 992; Phillips et aI., 1 997; Phillips,
Lyeth, Hamm, Reeves, & Povlishock, 1 998). The most likely explanation for the
shortening of inj ured dendrites is that ultrastructural fragmentation of microtubules and
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neurofilaments occurs within the varicosities, producing compaction of cytostructural
components along the process and thereby reducing the overall length.
Inglefield, Wilson, and Schwartz-Bloom ( 1 997) found similar beading of
interneuron dendritic processes IR for the GABAaR subunit a 1 following ischemia. The
formation of varicosities in ischemia, however, was delayed until three to four days post
injury and corresponded with delayed degeneration of CA 1 pyramidal cells. GABAaR
subunit IR appears to be sensitive to morphological dendritic pathology, and similar
dendritic alterations have also been found in microtubule and neurofilament
immunohistochemistry (Matesic & Lin, 1 994; Posmantur et ai., 1 996; Posmantur et ai.,
1 997; Saatman, Graham & McIntosh, 1 998), electron microscopy (Fekuda, Nakano,
Yoshiya, & Hashimoto, 1 993; Petito & Pulsinelli, 1 984; Yamamoto, Hayakawa, Mogami,
Akai, & Yanagihara, 1 990), autoradiography (Johansen, Jorgensen, Ekstrom von Lubitz,

& Diemer, 1 984) and tissue cultures (Adamec, Beermann, & Nixon, 1 998; Baar, 2000;
Emery & Lucas, 1 995; Ochs & Jersild, 1 987; Park, Bateman & Goldberg, 1 996). The
connection between all of these markers of ultrastructural change is that they were all
induced by some sort of exCitotoxic neuronal insult (e.g., TBI, ischemia, hypoxia).
Emery and Lucas ( 1 995) produced dendritic varicosities in cultured neurons
exposed to hypothermia, NMDA or A23 1 87 (a calcium ionophore). All three injuries
produced identical dendritic pathology. Fractured microtubules and swollen mitochondria
and vacuoles were found densely packed within the varicosities. The diameter of the
varicosities, however, was within normal dendritic range. The interconnecting portions of
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the dendrite (between the varicosities) were found to contain densely packed (mostly
unfragmented) microtubules with no large organelles present. This region was constricted
and the diameter was less than normal dendritic range. The somata of neurons with
beaded dendrites also showed nuclear changes, chromatin clumping, and cytoplasm
containing dilated vacuoles and dark mitochondria. In the hypothermic cultures,
rewarming eliminated the varicosities, indicating that this response to inj ury can be
reversed, at least in some cases (Emery & Lucas, 1 995).
Although the exact mechanism driving dendritic cytoskeletal alterations is
unknown, Mattson, Wang, and Michaelis ( 1 99 1 ) found that proteins associated with
hippocampal NMDA receptors are located in clusters along dendritic membranes. The
varicosities, therefore, may be associated with discontinuous receptor distribution.
Although NMDA involvement is likely, this does not explain the dose-dependent
expression of varicose dendrites following A23 1 87 calcium ionophore exposure.
Exposure to low doses of A23 1 87 showed no significant ultrastructural alterations in 40%
of cells, although higher doses resulted in necrosis, swollen or collapsed mitochondria
and nuclear changes similar to neurons exposed to NMDA. Rate-dependent beading of
dendrites was found in 47% of neurons. Therefore, a likely explanation for dendritic
beading would be a calcium-mediated mechanism induced by excessive neuroexcitation
(Emery & Lucas, 1 995).
It is well known that TBI-induced neuroexcitation is mediated by NMDA receptor
activation. NMDA receptor activation leads to the opening of ion channels and
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subsequent calcium influx (Alessandri & Bullock, 1 988; Mcintosh et aI., 1 996). NMDA
receptor- mediated calcium elevation is associated with protease activation (e.g., calpain),
which may be involved in the cascade that leads to dendritic cytoskeletal fragmentation
(Alessandri & Bullock, 1 988; Kampfl et aI., 1 997; Posmantur et aI., 1 997; Seubert, Lee,

& Lynch, 1 989; Siman, Noszek, & Kegerise, 1 989). Protease activation by calcium has
been shown to facilitate varicosities and interconnecting organelle loss and membrane
shrinkage (Ochs & Jersild, 1 987).
Lankiewicz et al. (2000) demonstrated that calcium activation of calpain I was
detectable in cultured rat hippocampal neurons that were briefly exposed to NMDA.
Mediated by the NMDA receptor, glutamate activates calpain, which breaks down
spectrin, a protein that links membrane proteins to the actin cytoskeleton (Adamec,
Beermann, & Nixon, 1 998). Spectrin has also been shown to selectively interact with the
C-terminal of NMDA NR2 subunits (Wechsler & Teichberg, 1 998). Furthermore,
glutamate mediation of calcium, rather than j ust an excess of calcium, is necessary for
calpain activation. Calpain I inhibitors, however, interfere with the normalization of
varicosities in hippocampal rat neuronal cultures exposed to sublethal levels of glutamate,
indicating that activation of appropriate levels of cal pain I may play a role in restoring
normal cytoskeletal organization (Adamec, Beermenn, & Nixon, 1 998). Calpain may
provide feedback regulation of NMDA receptors by limiting NMDA receptor activation
via truncation of the C-terminal domain of N2 subunits (Bi et aI., 1 998). Collectively,
these data would indicate that NMDA-mediated glutamate activity acts to increase
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intracellular calcium, which in tum activates calpain. Calpain alters cytoskeietal structure
by breaking down spectrin, although this may be a sublethal response that ultimately
restores cytoskeletal organization to normal by decreasing further NMDA receptor
mediated neurotoxicity
In TBI and other CNS inj uries, NMDA receptor-mediated glutamate activity
disturbs calcium homeostasis, which then activates a cascade of events that contributes to
cytoskeietal alterations and neurodegeneration. The role of calcium and calpain are
important contributors to this cascade. Calpain inhibitors administered within 24 hours of
injury have been shown to attenuate structural and functional derangements of neurons
(Kempfl et ai., 1 997). NMDA receptor antagonists such as MK-80 1 reduce glutamatergic
receptor activation, ultimately altering the neurotoxic cascade.
The role of NMDA in dendritic pathology was investigated in mouse neuronal
cultures exposed to hypoxia. Segmental dendritic beading occurred but was blocked by
the NMDA antagonist MK-80 I . Within five minutes of NMDA or glutamate exposure,
the varicosities returned and were again normalized with MK-801 treatment. Dendrites
which received longer exposure ( 1 5 or more minutes) demonstrated more extensive
beading of distal and proximal dendrites and a loss of dendritic spines. Cells exposed to
1 5 minutes of hypoxia were normal by 24 hours following injury. Although cell death due
to hypoxia or NMDA exposure was always preceded by dendritic beading, reduced length
of exposure resulted in sublethal dendritic cytoskeletal alterations (Park, Bateman &
Goldberg, 1 996).
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Similar to NMDA receptor antagonism, GABAaR agonists reduce overall
excitation, essentially preventing a detrimental cascade of subcellular events. Cultured
hippocampal pyramidal cells exposed to glutamate showed shortened dendrites and
inhibited outgrowth at sublethal levels and cell death at higher levels. A combination of
GAB A and DZ significantly reduced these dendritic alterations and prevented cell death.
The calcium channel blocker C02+ demonstrated similar neuroprotection, indicating that
GABAaR-mediated neuroprotection may have calcium-related effects (Mattson & Kater,
1 989). Indeed, whole-cell patch-clamp recordings from both tracheal smooth muscles
(Yamakage et al., 1 999) and neuronal cultures (Akaike, Oyama, & Yakuskij i, 1 989;
Ishizawa, Furwya, Yamagashi, & Dohi, 1 997) indicate that DZ and other benzodiazepines
decrease influx of voltage-dependent calcium currents. DZ was more effective than
midazolam in reducing calcium currents and the response was dose-dependent (lshizawa
et al., 1 997; Yamakage et al., 1 999). Conversely, DZ-binding inhibitors produce an
increase in intracellular calcium (Cosentino et al., 2000). Therefore, DZ treatment may
provide neuroprotection by increasing inhibitory tone and decreasing intracellular calcium
and subsequent calpain activation.
Elimination of dendritic pathology by MK-80 1 in tissue culture and by DZ in the
current study are likely both due to restoration of the balance between excitation and
inhibition, which ultimately reduces glutamatergic neurotoxic cascades. Since the FPI
used in the present experiment is not associated with overt cell death (Delahunty et al.,
1 995) it is likely that inj ury-induced morphological alterations are a sublethal response to
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the injury. Sublethal responses in the hippocampus may be associated with long term
deficits in spatial cognition. MK-80 1 (Hamm, O'Dell, Pike, & Lyeth, 1 993) and DZ
(O'Dell et aI., 2000) treatment have both been shown to attenuate MWM deficits 1 5 days
following central FPI. Alterations in the hippocampus have been implicated in producing
these cognitive deficits (Hayes, Jenkins & Lyeth, 1 992b). Sublethal NMDA receptor
mediated changes in long term potentiation (L TP) have been linked to cytoskeletal
alterations. Ca1pain, which is associated with LTP (Lynch & Baudry, 1 987) induces the
breakdown of spectrin. Interactions between spectrin and NMDA receptors are believed
to play an important role in LTP, as are glutamate-induced morphological alterations to
dendritic spines (Wechsler & Teichberg, 1 998).
Alterations in the CA3 may have been produced by glutamatergic mossy fiber
input from the DG and may in turn affect LTP associated with CA3 to CA 1 Schaffer
collaterals. Thus, the normalization by DZ of TBI-induced sublethal alterations in
hippocampal CA3 apical dendrites may have been due to a reduction in mossy fiber
glutamatergic neuroexcitation of the this region. Attenuation by DZ of changes in the
CA3 found at 24 hours may, therefore, be an important precursor to attenuation by DZ of
MWM deficits at 1 5 days (O'Dell et aI., 2000).
The current study provided evidence that irnmunolabeling of �2/3 subunits of the
GABAaR was altered following TBI. The pattern of changes in GABAaR IR was
different from changes found with anti-GABA antibodies. Dendritic pathology visualized
by GABAaR staining was attenuated by DZ treatment, demonstrating the importance of
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acute normalization of the balance between excitation and inhibition in the hippocampus.
The beaded and segmented appearance of inj ured apical dendrites in the CA3 was a
surprising result, which is likely due to cytoskeletal dendritic pathology that needs to be
further characterized.
Since this was the initial investigation into GABAaR changes following TBI,
further studies are needed for a greater understanding of GABAaR alteration and
manipulation following injury. Immunohistochemical characterization of other GABAaR
subunits such as

Ct I

and y2 may provide greater understanding of injury-induced

alterations of the GABAaR. Correlation of GABAaR IR with microtubule and
neurofilament changes may show that varicose and segmented portions of CA3 apical
dendrites coincide with ultrastructural changes. Electron microscopic analysis of dendritic
cytoskeletal rearrangements could be used to verifY IR alterations. Also, protein
expression is likely to be preceded by molecular alterations. Subunit specific
modifications in the DNA encoding for GABAaR proteins may provide further
understanding of GABAaR changes due to TBI. Another important aspect is the time
course following injury. A greater understanding of acute ultrastructural dendritic and
receptor changes may be found in the DG, CA l and/or CA3 regions at earlier time points
and the persistence of sublethal hippocampal pathology at chronic time points may help
explain long term cognitive deficits.
In conclusion, attenuation of TBI-induced GABAaR alterations with DZ may
provide a viable approach to the normalization of excitatory/ inhibitory balance in the
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hippocampus. Excessive neuroexcitation produces sublethal pathology that may include
ultrastructural alterations to hippocampal apical dendrites and these alterations may be
associated with subsequent cognitive deficits. This study provides further support for the
hypothesis that the inhibitory system is altered following TBI.
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